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ABSTRACT 
Recombinant Adenoviruses (Ads) have been shown to have potential 
applications in three areas: gene therapy, high level protein expression and 
recombinant vaccines.' At least three different locations within the Ad 
genome can be deleted and subsequently used for the insertion of foreign 
sequences. These include the Early 3 (E3), Early 1 (E1) and Early 4 (E4) 
regions. Viral vectors of this type have been well studied in Human Ads 2 
and 5, however one has not yet been constructed for Bovine Adenovirus 
Type 2 (BAV2). 
The E3 region is located between 76.6 and 86 m.u. on the r-strand 
and is transcribed in a rightward direction. The gene products of the Early 
3 region (E3) have been shown to be non-essential for viral replication, in 
vitro, but are required for host immunosurveillance. This study 
represents the cloning and reconstitution of a BAV2 E3 deletion mutant. A 
deletion of 1800bp was made within the E3 region of BAV2 and the 
thymidine kinase gene was subsequently inserted in the deleted area . . The 
plasmid pdlE3-4tk1 (23.4Kbp) was constructed and used to to facilitate 
homologous recombination with the wild type BAV2 to produce a mutant. 
Southern Blotting and Hybridization results suggest the presence of a 
BAV2 E3 deletion mutant with thymidine kinase sequences present. 
The E4 region of Human Adenovirus types 2 and 5 is located at the 
extreme right end of the genome (91.3 map units - 99.1 map units) and is 
transcribed in a leftward direction giving rise to a complicated set of 
differentially spliced mRNAs. Essentially there are 7 open reading frames 
(ORFs) encoding for at least 7 polypeptides. The gene products encoded by 
the E4 region have been shown to be essential for the expression of late 
viral genes, host cell shutoff and normal viral growth. We have cloned and 
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sequenced the right end segment between 90.5 map units and 100 map 
units of the BAV2 genome. The results show several open reading frames 
which encode polypeptides exhibiting homology to three polypeptides 
encoded by the E4 region of human adenovirus type 2. These include the 
14kDa protein encoded by ORF1, the 34kDa protein encoded by ORF6 and 
the 13kDa protein encoded by ORF3. The nucleotide sequence, restriction 
enzyme map, and ORF map of the E4 region could be very useful in future 
molecular manipulation of this region and could possibly explain the slow 
growth rate of BAV2 in MDBK cells. 
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CHAPTER 1: INTRODUCTION 
The Adenovirus (Ad) was first discovered in 1953 when Rowe and 
colleagues surgically removed the adenoids from 53 children . The slowly 
progressive cytopathic effect of the virus gave the virus the name 
"adenoid-degenerating (Ad) agent". Since then, Ads have been isolated 
from every studied species of placental mammals, marsupials, birds and 
amphibians . 
The classification of Ads is based on several properties. These 
include hemagglutination patterns, oncogenicity, DNA base composition 
and homology, relationship of T antigens and finally restriction enzyme 
patterns. Ads belong to the family Adenoviridae, which is further 
subdivided into two genera, Mastadenovirus and Aviadenovirus. Members 
of the genus Mastadenovirus infect human, simian, bovine, equine , 
porcine, ovine and canine hosts. The members of this group also possess a 
group specific antigen (Ag). Members of A viadenovirus infect avian 
species. 
Ads are nonenveloped icosahedral shaped virions which are 
approximately 65-80nm in diameter and made up of 13% DNA and 87% 
protein. Each virion contains a single molecule of double stranded DNA 
with a 55KDa protein covalently attached to each of its 5' ends. The 
genome IS divided into early and late transcription units. The early 
regions, E1 to E4, are transcribed before the onset of DNA replication, 
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whereas the late transcription units are transcribed after the onset of 
DNA replication. 
The early genes are particularly interesting because they encode 
protein products which. are necessary for DNA replication and late gene 
expression. However, the gene products of the E3 region are not required 
for viral replication in cell culture, but are believed to be responsible for 
host immunosurveillence and important for the establishment of long term 
infection. These two properties of the E3 region make it a good candidate 
for deletion and subsequent insertion of 4-5Kbp of foreign sequences for 
the construction of a recombinant viral vectors. 
A variety of literature exists on the construction of human Ad2 and 
Ad5 recombinant vaccines containing deletions within the E3 region. Ad 
vectors have been constructed that express glycoproteins from herpes 
virus (Johnson et a/ .. , 1988), hepatitis B virus (Morin et a/., 1987), human 
immunodeficiency virus type 1 (Dewar et a/., 1989), vesicular stomatitis 
virus (Schneider et a/., 1989), rabies virus (Prevec et a/., 1990) and the 
respiratory syncytical virus (Collins et a/., 1990; Hsu et a/., 1991). 
The primary objective of this study was to construct a recombinant 
BAV2 vector containing a deletion in the E3 region. If a recombinant BAV2 
vector was rescued, future experiments could be designed to insert a gene 
for an antigen in the E3 region, as has been done for Ad2 and Ad5. The 
application of a recombinant BAV2 vector expressing a cloned antigen 
gene in the deleted area could be as a recombinant vaccine for cattle or 
sheep. Such a vaccine would be valuable because it would be relatively 
cheap, easy to administer and it would provide long lasting immunity. 
Another region of the Ad genome which has been used for deletion 
and subsequent insertion of foreign sequences is the E4 region. A deletion 
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can be made between the start for E4 transcription and the right inverted 
terminal repeat as long as the virus is propagated in the cell line W162 
which provides the missing functions of the E4 region, in trans. The 
function of gene products encoded by the E4 region have been studied using 
E4 deletion mutants. E4 deletion mutants of Ad2 and AdS have a 10-20 
fold decrease in the final virus yield when compared to the wild-type as 
well as being inefficient for host cell shut off and late viral gene 
expression. 
During this study, the putative E4 region of BAV2 was sequenced and 
subsequently analyzed for two reasons: first, BAV2 was observed to grow 
slowly in MDBK cell line. Therefore, the possibility that E4 may influence 
BAV2's growth was investigated by sequencing and subsequently analyzing 
the ORFs of the E4. Secondly, the sequence and restriction enzyme map of 
the E4 region would be a very valuable tool in future studies involving 
deletions within the E4 region. 
1 3 
CHAPTER 2: LITERATURE REVIEW 
2.1 Adenoviruses 
Ads are nonenveloped medium sized DNA viruses with an inner DNA 
protein core enclosed by an icosahedrally shaped protein capsid. This 
outer capsid consists of 20 triangular surfaces and 12 vertices. A fiber 
projection extends from each of the 12 vertices and the length of the fiber 
varies amongst serotypes (Norrby, 1966: 1969 and Horwitz, 1990). The 
protein coat is composed of 252 subunits called capsomeres. Of these 252 
capsomeres, 240 are hexons and 12 are pentons (Ginsberg et al., 1966 and 
Horwitz, 1990). Each penton contains a fiber projecting from a penton 
base on the surface of the capsid . The penton base is surrounded by 5 
hexons, hence the name "penton". All other capsomeres are hexons because 
each one is surrounded by six other capsomeres. The double stranded DNA 
is sheltered in the core structure and contains a 55kDa terminal protein 
which is covalently attached to each of the the 5' ends of the viral 
genome. 
Most detailed structural protein strudies have been carried out for 
human Ad types 2 and 5. The location of these viral polypeptides has been 
determined by surface labelling of the virion as well as analysis of 
degraded virions (reviewed by Horwitz, 1990). Figure 1 represents the 
various Ad2 capsid proteins and their positions relative to the core which 
shelters the double stranded genome. Polypeptide II is a 120kDa hexon 
II Hexon 
III - Pentonbase 
IV - Fiber 
III a - Penton associated 
protein 
V - Core protein 
VI - Hexon associated 
protein 
VII - Core protein 
VIII - He xon associated 
protein 
IX - Protein specific for 
group of nine hexons 
Figure 1: A diagrammatic representation of the adenoviral capsid 
proteins and their positions relative to the double stranded 
genome. (taken from Horwitz 1990) 
14 
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polypeptide. The hexon capsomeres are made of a trimer of 3 identical 
polypeptides held together by. noncovalent interactions. The 100kDa 
protein is required for the assembly of the hexon trimer from monomers. 
Each hexon is associated with 6 other hexons through polypeptide IX 
(12kDa). Hexons are also associated with viral polypeptides VI (24kDa) 
and VIII (13kDa) to form the triangular surfaces of the viral capsid. 
Polypeptides V (48.5kDa), VI, VII (18.5kDa) and VIII are located within the 
core of the virion. Polypeptides V and VII are associated with the double 
stranded DNA molecule, whereas polypeptides VI and VIII are located 
within the internal surface of the hexon. The amino terminus end of the 
fiber is noncovalently attached to the penton base whereas, the carboxy 
knob is projecting away from the virion capsid (reviewed by Horwitz, 
1990). 
The various structural polypeptides characterize this group of 
viruses in various ways. Serological classification of Ads involve 
antigenic determinants which are present on the hexon, penton and fiber. 
Ad hemagglutinins are properties of the fiber and the penton base 
polypeptides and are related to the cytopathic effect (ePE) observed 
during Ad infection in cell culture (reviewed by Horwitz, 1990). 
2.2 Classification 
Ads belong to the family Adenoviridae which is subdivided into two 
genera Mastadenovirus and Aviadenovirus. The difference between the two 
genera is a group specific antigen present only in the genus 
Mastadenovirus. The genus Aviadenovirus includes Ads which infect avian 
hosts (fowl, turkey, goose, pheasant and duck). The genus Mastadenovirus 
ADENOVIRIDAE 
MASTADENOVIRUS AVIADENOVIRUS 
HUMAN ADS 
CANINE 
OVINE 
EQUINE 
BOVINE ADS AVIAN ADS 
ADS 
SUBGROUP 1 
Bav 1,2, 3 and 9 
SUBGROUP 2 
Bav 
4-8,10 
Figure 2: Diagrammatic representation of the classification of the 
family Adenoviridae. 
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consists of viruses isolated from mammals (man, monkey, cattle, pig, 
sheep, horse, dog, goat and mouse (Joklik, 1988) (See Figure 2). 
Mastadenovirus is further subdivided into Bovine Adenoviruses 
(BAV) and other Ads which infect human, canine and ovine hosts. BAVS are 
further subdivided into two groups based on different serotypes. Group I 
includes serotypes 1, 2, 3, and 9. Group II includes serotypes 4-8 (Bartha, 
1969 and Horwitz, 1990). 
Ads have a large number of different hosts and over 80 different 
serotypes of mammalian adenoviruses and avian adenoviruses have been 
reported, forty- seven of them from human hosts (Herholzer, 1988). 
Forty-seven of the human serotypes are further divided into six subgenera 
(A to F) based on sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis. (SOS-PAGE) of polypeptides (See table 1) (reviewed by 
Wadell, 1994). 
The six subgenera of human serotypes have been classified based on 
a number of characteristics such as hemagglutination patterns, Ge content 
and restriction endonuclease digestion by Sma (Table 1). 
Hemagglutination by Ads was first demonstrated by Rosen in 1958. The 
G+C content of the DNA of each subgenus differs: subgenus A 48%, 
subgenus B-1 and B-2 51 %, subgenus e 58%, subgenus 0 58%, subgenus E 
58% and subgenus F 52%. It was generally found that low G+C content 
(48%) of group A correlated with tumor induction whereas group e (58%) 
are not oncogenic. Sma I cleaves the DNA at 5 'cee GGG, therefore 
fragments obtained after restriction endonuclease digestion are 
characteristic of the subgenera of human serotypes (reviewed by Wadell 
et al., 1985). 
Subgenus 
A 
B:I 
B:2 
C 
D 
E 
F 
DNA Apparent molecular mass 
._-- _.- '- , of the major internal 
Homology (%) Number polypephtlcs (k(")) Hemal:' Len&th ,Oncogenicity 
G+C of Sma!' -~_ . . - _. glutination of rlber; in newborn Tropism 
Semtype Intrageneric Intergeneric (%) fragments V VI VII patternb (nm) hamsters symptoms 
--------
12.IB.31 ~B-69 B-20 1B 4-S SI.O-SI.S 25.5-26.0 IB IV 2B-31 High (tumors Cryptic enteric 
46.S-4B.S' in most animals infeChon 
in 1 months) 
3.7.16.21 89-94 9-20 SI 8-10 S3 .S-S4 .S 2~ 18 9-11 Weak (tumor; 
14 .dIU4. in few animals 
3S in 4- 18 
months) 
1.2.S.6 99-100 10-16 SB 10-\2 '1B.5 2~ 18.5 \\I 23-31 Nil 
8.9.10.13. 9"1-99 "1-17 58 I~ - 18 50.0-50.5' 23.2 18.2 12-13 Nd 
IS. 17.19,20. 
22 to 30.32.33. 
36.37.38.39. 
'12 to 47' 
~ ~ - 23 5[) 16 ··19 ~[) HS I[) \\I 17 Nil 
40. 41 62-69 IS-22 S2 9-12 46.0-"I8.S 25 .5 17.5 IV 28-33 Nil 
Table ' 1: Properties and Characteristics of the human adenovirus 
serotypes of the subgenera A-F. 
Respiratory 
disease 
Pcr'~stent 
infections of 
the kidney 
Respir a tory 
disease per· 
SIS : S In lymph , 
oid tissue 
Keratocon· 
junctivltis 
Conjunc.tlv.\ I ~ 
Resplr 310ry 
disease 
Infantile 
diarrhea 
....... 
00 
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The DNA homology between serotypes of subgenera is only 4-23%. 
However, DNA homology between members of the same subgenus is greater 
than 48% (Green et al., 1979). Sequence divergence between members of a 
single group has been found to be greatest in regions coding for the hexon 
capsomere and the fiber. The hexon and fiber are polypeptides to which 
the host's antibodies are directed, therefore variation would be expected 
here. 
2.3 Ad infection 
The normal life cycle of human Ads involves either a lytic infection 
or a latent infection. The lytic infection ultimately results in the 
destruction of the infected cell. An Ad lytic infection within group C is 
very efficient at the production of new virions and may result in the 
production of approximately 10,000 virions per infected cell (Green et al., 
1961) . An Ad first attaches to a specific receptor on the host's cell 
membrane and then adsorbs and penetrates through the cytoplasmic 
membrane via clathrin coated pits which form endocytic vesicles. When 
the virus enters the cell, the pH drops to 5.5 resulting in the disruption of 
the endocytic vesicle and the release of the virus into the cytoplasm. . The 
virus is then transported across the cytoplasm to the nucleus of the cell 
via micrbtubules where uncoating takes place. Parts of the genome are 
transcribed and the double stranded genome replicates. Viral mRNA are 
then tranported to the cytoplasm, where they are later translated into 
viral proteins on cytoplasmic polysomes. The viral proteins are then 
transported back to the nucleus where virions are assembled (reviewed by 
Horwitz, 1990). 
20 
A latent infection involves the virus persisting within the host cell 
without eliciting an immune response. Integration of Ad viral DNA into a 
host's genome at selective sites can result in "insertional mutagenesis" 
which seems to be associated with the initiation of viral malignant 
transformation (Doerfler and Bohm (eds) 1992). The oncogenic potential 
of Ads was first observed by Trentin et al. in 1962 and since then has been 
used as a characteristic for dividing Ads into subgenera. 
2.4 Ad genome 
2.4.1 DNA replication 
The Ad genome consists of a double stranded molecule of 
approximately 36,000 bp in size (Joklik, 1988) enclosed in a protein 
capsid. The organization of the genome is similiar in all Ad groups. The 
viral genome is bracketed by inverted terminal repeats (ITR) which flank 
the coding regions and are used during Ad DNA replication. These ITRs 
consist of 54-166 nucleotides possessing the structure ABCD __ D'C'B'A'. 
All animal Ads studied have conserved this feature (reviewed by Horwitz, 
1990) (see Figure 3). 
DNA replication begins about 7 hours post infection. The replication 
of Ad DNA proceeds in a semi-conservative fashion beginning at origins of 
replication (ORI) located at nucleotides 1-18 in either ITR. DNA 
replication requires virally encoded pTP, DNA binding protein (DBP) and Ad 
DNA polymerase (140kDa) as well as a series of cellular factors (NFl, 
NFIII, and ORPA). The cellular factors bind to the ORI where they interact 
with pTP and Ad DNA polymerase to form a protein/DNA complex. 
Replication IS initiated when the protein/DNA complex covalently 
attaches the pTP to dCTP to form a pTP-dCMP complex which presents a 
[ Ad 16 ~----------~~~--~ ~~~ 
.. · ........ · ...... ···1 ~~~6 
Ad41 
r ________ ~::::::::::::::::::::::==Ad4 1 Ad 9 
CaAd·' 
................................ cr? I ~i i~ 
............... tr -----1========== fcAHV (Ca) 
....................................... AdFL 
............................................ 1 ~~~ 1 
·• .. · .... · ...... ·· .. ··· .... · .... ·· .... ·· .... · .... 1 ~~Xd2 
1...-.. ______ • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •• 8 A V 3 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• EDS76 
1 24.1 '-------------------------................................................................................................................ Ad 1 a 
120 100 80 60 40 20 0 
Figure3 : Phylogenetic tree comparing the ITR's of Human Adenoviruses (AdI2, Ad18, Ad31, Ad3, Ad7, 
AdI6, Ad2, AdS, Ad9, AdlO, Ad4, Ad34, Ad40, Ad41), Canine Adenoviruses CICHY, CAd2, CaAd-
1), Equine Adenovirus (EAd), Bovine Adenoviruses (BA VI, BA V2, BAV3), Rodent Adenovirus 
(AdFL), Shrew Adenovirus (TSAd) and Avian Adenoviruses (CELO, EDS76). 
tv 
...... 
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free 3'-OH group serving as a primer for elongation by Ad DNA polymerase. 
Elongation occurs until the displacement of one strand occurs as outlined 
in Figure 4. The displaced strand forms a panhandle structure through the 
annealing of complementary ITRs and subsequently serves as a substrate 
for the initiation of the synthesis of the double stranded genome. 
2.4.2 Ad gene expression 
The study of the Ad gene structure and gene control has lead us to 
understand of many of the principles we adhere to today. The definition 
that the start site of polymerase /I transcription specified the mRNA 5' 
end, the discovery of RNA splicing, the finding that RNA cleavage rather 
than transcription termination generated the mRNA 3' end and the 
development of systems for in vitro transcription that allowed for the 
isolation of transcription factors were all recognized first using Ad 
systems (reviewed by Nevins, 1987). 
Most of the Ad, genes are transcribed in a series of steps regulated 
by viral promoters and cell encoded transcription factors. These 
transcription factors recognize specific nucleotide sequences located 
within the viral promoters which are situated upsteam and certain 
downstream regions of the viral genes (reviewed in Deofler, 1994). 
The replication of the Ad is divided into 2 phases: early, 
corresponding to the events occurring before viral DNA replication and 
late, corresponding to events after the initiation of DNA replication. 
However, many early regions continue to be transcribed after the 
initiation of DNA replication. The late regions are then sequentially 
transcribed. During the early phases, 4 regions of the genome are 
expressed: Early region 1 (E1), which contains E1 a and E1 b; E2, which 
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Figure 4: A proposed model for Adenoviral DNA replication (Joklik, 1988), 
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contains E2a and E2b; E3; and E4. The transcription of these regions is 
driven by promoters situated within the viral genome. After the initiation 
of DNA replication, the major late promoter (MLP) initiates viral 
transcription of all the lBte regions (L 1 to L5) of the genome (reviewed by 
Sharp, 1984) . The late regions are responsible for the production of 
structural virion proteins. Components of the MLP are located at about 17, 
20, and 27 map units on the viral genome. 
Specific viral functions can be encoded on one of the two viral DNA 
strands . The two strands have been termed rightward transcribed (or 
upper) or leftward transcribed (or lower) strand. The structure and the 
genome map of early viral mRNAs have been determined a number of ways 
including electron microscopy, S1 nuclease mapping, in vitro translation 
of hybrid RNA and complementary DNA cloning (Nevins, 1987). As 
mentioned above, during the early phase, four regions of the the Ad genome 
are transcribed. Three of these early regions (E1 a, E1 b, and E3) are 
transcribed in a rightward direction and three regions (E4, E2a and . E2b) 
are transcribed in a leftward direction on the strand (See Figure 5). The 
late regions (L 1 to L5) are all transcribed in a rightward direction on the r 
strand. 
2.5 E1 region 
During the early times of infection, the E1 region is the first region 
to be transcribed. The primary transcript of this region is processed to 
give a complicated set of mRNAs responsible for the production of 
specific gene products having some important biological function (Graham 
et al., 1974; Gallimor et al., 1974 and van der Eb et al., 1974), one of 
which is the transformation of cells . 
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from Joklik 1988). 
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The expression of the E1 region is required for the expression of all 
other viral genes. The._ three major mRNAs transcribed from the E1 a gene 
are: 128, 138, 98. The 98 mRNA is transcribed only late in infection, 
whereas 128 and 138 are transcribed in both early and late times of 
infection. The gene products of the 98 mRNA and their functions are not 
well understood. In group CAds, 128 and 138 encode two proteins. These 
are termed 289R and 243R based on the number of amino acids they are 
composed of (Perricaudet et a/., 1979; Ricciardi et a/., 1981 and Gaynor et 
a/., 1982). The two proteins are distinguishable by the unique 46 amino 
acids at positions 140-185 in the 138 mRNA. It is this unique region 
which is the trans-activator and is required for the expression of all 
other viral genes. Point mutations located within this unique region of 
the 138 mRNA have resulted in the production of virus which is impaired 
for growth and virus gene activation (reviewed in Moran and Mathews, 
1987). 
There are three domains of the E1 a which are conserved among Ad 
serotypes. These include conserved regions [CR] 1, CR2 and CR3. It is the 
CR3 which encompasses the 46 amino acids which are unique to the 138 
mRNA. CR1 and CR2 have been found to be responsible for cell 
transformation, the induction of DNA synthesis, repression of 
transcription functions of the E1 a unit (Cogan et a/., 1992) and induction 
of TNF-independent cytotoxicity (reviewed by Gooding and Wold, 1990). 
The negatively acting regulatory component of the E1 a region was 
demonstrated with protein synthesis inhibitors. Cycloheximide has been 
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shown to increase early viral RNA production in the absence of protein 
synthesis (Nevins, 1987). 
The E1 a region also exhibits nonconserved regions which have no 
effect on the trans-activation of other Ad genes when these regions are 
deleted. However, nonconserved regions such as the E1 a C terminus have 
been shown to somehow affect the rapid nuclearization of E1 a gene 
products (reviewed in Moran and Mathews, 1987). 
Transcription of the E1 b region results in the production of two 
mRNAs from two overlapping reading frames: 228 and 138. The 228 mRNA 
encodes both 19kDa and 55kDa proteins. The 138 mRNA encodes a 19kDa 
polypeptide (Bos et al., 1981). The 19kDa protein is multifunctional 
(reviewed by Gold et al., 1990a) and plays a role in preserving the nuclear 
DNA integrity and cytoplasmic architecture which is destroyed by E1 a 
gene products during productive infection (White, 1992). The infection of 
baby rat kidney cells with Ad12 mutants which lacked the gene for 
the19kDa protein illustrated this protein 's function. Cells infected with 
this mutant resulted in degradation of the infected cell and viral DNA 
(Zhang et al., 1992). This observed phenotype was believed to be a result 
of the inability of the 19kDa protein to preserve the structural 
components of the cells . More recently, it has been shown that the E1 b 
encoded 19kDa protein protects the Ad infected cell against destruction 
from the tumour necrosis factor (Gooding et al., 1991 a; White et al., 
1992). This role led to the suggestion that this E1 b gene product may be 
important in allowing the E1 a to completely transform nonpermissive 
cells by preventing the host cell's destruction by TNF (White et al., 1992). 
The 19kDa protein has also been shown to have trans-activation functions 
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for E1 a, E1 b, E2, E3, E4, and the cellular heat shock promoter (hsp70) 
(McGlade et al., 1987; Yoshida et al., 1987). 
The 55kDa protein encoded by the E1 b region is believed to be 
required along with tha E1 a gene products to produce full transformation 
of cells, in vitro. The 55kDa protein also forms a complex with the 34kDa 
protein produced by the E4 region. The formation of this complex is 
thought to be functional for the transport of cellular mRNA to the 
cytoplasm, thus preventing the accumulation of mRNA. Mutants that carry 
lesions in genes for either of the polypeptides display similiar lytic 
growth phenotypes: defects in viral DNA replication and late-gene 
expression (Cutt et al., 1987). 
2.6 E3 region 
The E3 region is located between 76.6-86.2 m.u. on the r-strand of 
the viral genome. About nine overlapping mRNAs (a to i) are expressed by 
alternative processing of a single primary transcript that initiates .trom 
the E3 promoter (Chow et al., 1979; Cladaras et al., 1985; Wold and 
Gooding, 1991). Figure 6 illustrates the processed mRNAs and the two 
polyA sites (E3a and E3b) of the E3 region. Out of the nine proteins 
encoded by this region in group C adenoviruses, six have been identified. 
These are 6.7kDa (Wilson-Rawls et al., 1990), glycoprotein 19kDa (Persson 
et al., 1980), 11.6kDa (Wold et al., 1984), 10.4kDa (Tollefson et al., 
1990a), 14.5kDa (Tollefson et al., 1990b), and 14.7kDa (Tollefson and 
Wold, 1988; Wang et al., 1988). Four of these proteins have been 
characterized. They include a 19kDa glycoprotein, 14.7kDa protein, 
14.5kDa, and a 10.4 kDa protein (reviewed by Wold and Gooding, 1991). 
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Figure 6: . A diagrammatic representation of the transcripts of the E3 
region. The exons of this region are represented by the solid 
arrows whereas the dashed lines represent introns. The 
protein products encoded by this region are represented by 
the cross-hatched boxes. (taken from Tolleffson et all. 1992). 
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The 19kDa glycoprotein was shown to complex with Class I Antigen 
of the major histocompatibilty complex (MHC) in the endoplasmic 
reticulum (ER). This blocks the transport of Class I antigens to the cell 
surface protecting the .cell from destruction by the cytotoxic T cells. This 
was first demonstrated in Ad2 transformed rat cells (Kvist et a/., 1978). 
The net effect of gp19kDa being retained in the ER and binding to Class I 
antigens is to block the transport of Class I antigens to the cell surface. 
Therefore, this gene product plays a major role in viral oncogenesis. 
Transformed cells are permitted to grow because the immune system of 
the host will not recognize and destroy them. The 19kDa and 14.7kDa gene 
products are also thought to be involved in protecting latently infected 
cells from destruction by the immune system (reviewed by Wold and 
Gooding, 1991). 
The 14.7kDa protein prevents the lysis of the infected cells by tumor 
necrosis factor (TNF). TNF IS a multifunctional cytokine that is secreted 
by activated macrophages and lymphocytes and is responsible for 
regulating a wide variety of aspects of the immune system and the 
inflammatory response (reviewed in Beutler and Cerami, 1989). Gooding 
et a/. (1988) showed that mouse fibroblasts are lysed by TNF when 
infected by adenovirus mutants that lack the E3 region. Uninfected cells 
were not lysed by TN F, nor were cells infected by the wild-type virus. The 
14.7kDa protein is not the only gene product encoded by the E3 region 
which protects infected mouse cells from destruction from the TNF. The 
10AkDa and 14.5kDa proteins appear to exist in a complex and can also 
prevent TNF lysis (Gooding eta/., 1991b). 
The 10AkDa and 14.5kDa proteins are thought to function together to 
down-regulate the epidermal growth factor receptor (EGF-R) in adenovirus 
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infected cells. Normal binding of the epidermal growth factor to its 
receptor results in the internalization of this complex in clathrin-coated 
pits via endosomes which are subsequently degraded in Iysosomes. This 
activity results in ce.llular metabolism, DNA synthesis and mitosis 
(reviewed in Wold and Gooding, 1990). An Ad infection mimics the EGF in 
that the EGF-R is still taken up via endosomes, internalized and degraded. 
Little is known about the mechanism of action of this complex 
(10.4kDa/14.SkDa), only that both are cytoplasmic membrane proteins, and 
which may localize to the cytoplasmic membrane where they interact 
with the EGF-R. 
The deletion of the E3 region does not affect viral replication in cell 
culture. However, the gene products of this region are required to prevent 
destruction of the virally infected cells from the host's immune system 
and therefore play an important role in the establishment of long term 
infection in vivo (reviewed by Ginsberg et al., 1989). Therefore, Ads have 
been attractive for their usage as recombinant viral vectors because 
foreign genes can be cloned in deleted E3 regions without the virus losing 
its ability to replicate in cells. However, their inability to counter host 
immune response results in a shorter duration of infection. 
2.7 E2 region 
The early region 2 is divided into E2a and E2b, each giving rise to 
their own gene products which are essential for the replication of viral 
DNA. The gene product encoded by the E2a region specifically controls 
transcription. The 72kDa DNA binding protein (DBP), appears to mediate 
the rapid decay of early mRNA. It has been observed that in the absence of 
this gene product, there is an overproduction of each viral mRNA. 
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E2b encodes polymerase and the terminal protein precursor (pTP) 
which are both required for the replication of adenoviral DNA. The pTP is 
87kDa polypeptide which when complexed with the first deoxycytidyl 
triphosphate (dCTP), serves as part of the primer required for the growing 
DNA chain. The pTP is sequentially cleaved giving rise to the terminal 
protein (TP) which remains covalently linked to the 5' end of the DNA 
(review by Horwitz, 1990). 
2.8 E4 region 
The E4 region of the Ad genome is located at the extreme right end 
between 91.3 map units and 99.1 map units. The region is located on the I 
strand and is transcribed in a leftward direction giving rise to a 
complicated set of mRNAs (See Figure 7). There are six polypeptides 
encoded by this region's 7 open reading frames. Three polypeptides 
encoded by the E4 region have been identified and assigned to a specific 
open reading frames: an 11 kDa protein (Sarnow et al., 1982), a 34kDa 
protein (Sarnow et al.,1984) and a 19kDa protein. The 34kDa protein is 
known to form a complex with the large E1 b protein which acts to inhibit 
host-cell protein synthesis at late times post infection (Sarnow et al., 
1984). Other polypeptides encoded by the E4 region have been identified 
but have not been assigned to any specific ORF. 
The investigations into the function of the gene products' of the E4 
region has been facilitated by observing Ad E4 deletion mutants. (Sandler 
and Ketner, 1989, Yoder and Berget, 1986). Human Ad types 2 and 5 with a 
large deletion within the E4 region of their genome have been found to 
suffer a reduction in the accumulation of late mRNAs both in the nucleus 
and the cytoplasm of infected cells and have also failed to shutoff host 
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Figure 7: Physical map illustrating E4 mRNAs, coding regions and their 
location within the right end of Adenovirus type 5. The E4 mRNAs are 
transcribed in a leftward direction as represented by the arrows. The 
protein encoding sequences are represented by open boxes and the cap site 
and poly(A) site are represented at positions 324bp and 3136bp, 
respectively. 
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cell protein synthesis. These E4 deletion mutants are defective in late 
viral protein synthesis and DNA accumulation (Sandler and Ketner, 1989; 
Yoder and Berget, 1986). Viruses containing a deletion specifically in 
ORF6 which encodes the 34kDa protein were found to display a lag in the 
onset of viral DNA replication, decreased levels of late proteins, 
inefficient shutoff of host cell protein synthesis and a 10-20 fold 
decrease in the final virus yield. Viruses with deletions in ORFs other than 
ORF6 behaved like the wild type virus (Huang and Hearing, 1989). 
The efficiency of viral replication is dependent on the production of 
large amounts of viral DNA and the synthesis of proteins which are 
necessary for assembly of the viral capsid during late times of infection. 
The synthesis of late mRNA is dependent on the production of several gene 
products during early times of infection. These products include those 
encoded by E1 a, E1 band E4 regions. As previously mentioned, the E1 a 
region encodes a protein which is 289 amino acids long, and is responsible 
for the trans-activation of the remaining early viral genes (Jones . and 
Shenk, 1979, Kovesdi et al., 1986 and Berk, 1986). It has been proposed 
that the E1 a activation of the Ad E2 promoter involves the activation of a 
cellular factor, E2F (Nevins, 1986,1987). This activation of E2F results in 
the production of a new form of E2F which binds to two sites located on 
the E2 promoter, thus facilitating transcription. The same activation of 
E2F has been observed by gene products encoded by the E4 region of the Ad 
genome (Marton et al., 1990). 
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2.9 Late regions 
Five families of late transcripts are synthesized by the major late 
promoter (MLP) beginning at 16.4Sm.u. on the r strand and continuing 
through to approximately 99m.u . At least 12 mRNAs are processed from a 
primary late transcript. Each mRNA contains polyA signals at the 3' end 
and a tripartite leader is spliced to the 5' end. Although the onset of viral 
DNA replication represents the beginning of the late phase, the actual 
mechanism responsible for the switch from early to late is not well 
understood . In attempts to understand the switch from early to late, 
experiments involving Ad2 and AdS have been done. These experiments 
determined whether or not unreplicated DNA would be able to express late 
genes when added to a cell in which late viral transcription was already 
active. AdS was the primary infecting virus which was allowed to 
. proceed to late transcription and Ad2 was subsequently added to cells. 
Late transcription did not occur from Ad2, suggesting that cis-acting 
factors play a role in the switch from early to late transcription. 
Most of the proteins encoded by the late region are virion structural 
proteins. However, some nonstructural early proteins such as the DBP 
continue to be synthesized during late times of infection. Other 
nonstructural proteins produced during late times of infection include the 
100kDa, SOkDa and 39kDa proteins which are involved in the assembly of 
progeny virions. The 100kDa phosphoprotein is a scaffold protein which is 
necessary for virion assembly. However, it is absent from the finished 
product. It binds· to a hexon monomer and is then released upon the 
formation of a trimer (reviewed in Horwitz 1990). The SOkDa and 39kDa 
proteins act as scaffolds during the formation of the capsid . 
36 
Some late mRNAs are also produced early in Ad infection. L 1 mRNAs 
are produced during the immediate early times of Ad infection. L2 and L3 
mRNAs have also been detected during during early gene expression, 
whereas L4 and L5._ have not (reviewed by Horwitz, 1990). Late 
polypeptides are synthesized at a maximum rate at 20 hours post 
infection. 
2.10 Bovine adenoviruses 
Bovine Adenoviruses (BAV) were first discovered by Klein et at. in 
1959. Since then, BAVs have been isolated from a wide variety of hosts, 
including cattle and sheep (Belak and Palfi, 1974), free living buffalo 
(Baber and Condy, 1981), and fallow deer (Boros et a/' J 1985). BAV 
infections result in symptoms characteristic of other adenoviral 
infections: respiratory tract disease, enteritis, conjunctivitis, keratitis 
and pyrexia (Darbyshire et a/' J 1966; Mohanty, 1971; Mattsson, 1973). 
There are ten serotypes of BAVS, differentiated based on serum 
neutralization and complement fixation tests. The ten serotypes are 
divided into two subgroups : subgroup I which includes serotypes 1, 2, 3, 
and 9 and subgroup /I which includes serotypes 4, 5, 6, 7, 8, and 10 . . The 
members of subgroup I share the antigen common to all mastadenoviruses 
and have been shown to grow in bovine testicular and kidney cells and in 
continuous cell lines such as Madin-Darby bovine kidney (MDBK) cells 
(reviewed by Ishibashi and Yasue, 1984). Members of subgroup /I do not 
carry a common antigen and they have been shown to only grow in bovine 
testicular, corneal or embryonic lung cells. (Bartha, 1969) . A DNA 
homology study carried out by Benko et at. in 1990 showed that there is 
37 
extensive DNA homology between members of subgroup II, but very little 
homology was detected between members of subgroup I. 
The genetic relatedness between members of subgroup I and 
subgroup II BAVs and between BAVS and human Ads has been investigated 
using DNA hybridization tests, hemagglutination test, ELISA and gel 
diffusion assay. The genetic relatedness of members of subgroup I to 
human Ads is variable and especially low for BAV1 and BAV2 (Belak et al., 
1983; Benkoet al., 1990). However, a close genetic relatedness was 
demonstrated between members of subgroup II BAVs by DNA hybridization, 
whereas no homology was detected between subgroups I and II or between 
subgroup II and human Ads (Benko et al., 1990) . 
There are a limited number of DNA homology studies comparing BAVs 
to human Ads. Two regions of the Ad2 genome encoding for the hexon 
(polypeptide II and IV protein) have been found to be homologous to BAV7 
(Hu et al., 1984). Sequences located between 10 to 80m.u. of the BAV3 
genome were found to share homology to the Ad2 genome. Consequently, 
the hexon protein was found to have greater than 80% identity to over 
70% of the coding sequences. 
The oncogenic potential of BAV3 and BAV8 have been demonstrated 
in newborn hamsters (Darbyshire, 1966; Mohanty, 1971). Newborn 
hamsters inoculated with BAV3 have been observed to produce 
undifferentiated sarcomas at the site of inoculation (Darbyshire, 1966). 
However, tumors were not observed in hamsters inoculated with BAV 
types 1, 2, 4, 5, 6, 7, and 9. As mentioned before, the genome of highly 
oncogenic types have a low G+C content, whereas nononcogenic types have 
a high G+C content. The genome of BAV3 was found to have 48% G+C 
compared to 62% and 61 % for BAV1 and BAV2, respectively (Panigrahy e t 
38 
al., 1977). Extensive DNA homology exists between BA V3 and Ad2, 
therefore it isn't surprising that the transforming region of BAV3 has 
been localized to the left end (Igarashi et al., 1978; Elgadi et al., 1993) of 
the genome as in Ad2. ". 
Very few detailed studies have been published concerning the 
biological properties of BAVs (Mohanty, 1971; Adair and McFerran, 1976; 
Benko et al., 1988). However restriction enzyme maps which are essential 
for detailed analys is of BAV genomes have been constructed for BAV1 
(Bendo and Harrach, 1990), BAV2 (Belak et al., 1983, 1986; Salmon et al., 
1993), BAV3 (Kurokawa et al., 1978; Elgadi and Haj-Ahmad, 1992), and 
BAV7 (Hu et al. 1984). More detailed studies of BAVs are needed. 
2.10.1 Bovine adenovirus type 2 
BAV2 was first isolated by Klein et al. in 1960 from the feces of 
apparently healthy cattle. BAV2 infection results in respiratory and 
intestinal disorders in both bovine and ovine species. BAV2 has been 
divided into two subspecies based on hemagglutination properties and 
restriction enzyme patterns. Subspecies A refers to isolates similiar to 
that used during this study (strain #19) and were originally isolated from 
cattle, whereas subspecies B were originally isolated from sheep and 
were found to be closely related to ORT-1I1 (Belak et al.,1983). Rusvai e t 
al., (1988) showed a close antigenic relationship between subspecies A 
and B when 8 monoclonal antibodies raised against BAV2 hexon cross 
reacted with both subtypes. The main difference between subgroups A and 
B seems to be within the E3 region sequences which encode for the fiber 
protein . Differences in the fiber protein would account for the 
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differences in host immunosurveillence and may explain why one 
subspecies is capable of infecting both bovine and ovine species . 
2.11 Recombinant adenoviral vectors 
Viral vectors can be utilized in two different ways; first, as high 
level expression systems for the production of an antigen or second, as 
live recombinant vaccines . Ads have been used as both expression vectors 
for the production of protein in mammalian cells and as vaccines for the 
immunization of humans and animals against many different diseases. 
More recently Ad vectors are being used as transducing viruses for gene 
the rapy. 
Ads are receiving attention as expression vectors and recombinant 
vaccines for several reasons: The viral genome is relatively stable and 
doesn't undergo rearrangement at a high rate. Therefore if a foreign .gene 
is inserted, it will be maintained throughout the replication of the virus. 
The development of extensive restriction endonuclease maps has made the 
manipulation of the genome of Ads relatively easy using recombinant DNA 
techniques. Ads are capable of efficiently infecting nondividing cells and 
expressing large amounts of gene product from sequences cloned in 
deleted E1 and E3 regions. This makes them attractive for the purpose of 
both expression vectors and recombinant vaccines. 
The early regions of the genome are important for the construction 
of recombinant viral vectors. There are three regions of the viral genome 
which can accept insertions of foreign DNA to generate a helper 
independent virus. These are E1, E3 and a short region between E4 and the 
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end of the genome (Graham and Prevec, 1991). The amount of DNA that can 
be packaged in virions is approximately 105% of the wild type genome 
which is approximately 2Kbp of DNA (Ghosh-Choudhury et al., 1986). If 
any more that this is inserted into the viral genome the result is 
instability and rapid rearrangement of the genome to lose the expgenous 
DNA (Bett et al., 1993). In order to insert larger segments of exogenous 
DNA into the Ad genome, the genome can be engineered by deleting viral 
sequences located within the E1 and E3 regions. 
The E1 gene products are essential for the expression of the 
adenoviral genome and normal viral growth. The engineering of 293 cells 
(Graham et aI, 1977). which provide the essential gene products encoded 
by the E1 region in trans has allowed deletions of up to 3.4Kbp of viral 
sequences within the E1 region to be made (Graham and Prevec, 1992). 
Adenoviral vectors can be made with deletions in the E1 region. 
However, in order for the vector to be able to replicate in 293 cells 2 
subregions must be retained in the E1 region. These two subregions are 
the left ITR (1-103bp) and the packaging signals (194-300). The protein 
IX gene and must also be retained for the viability of the vector. High 
expression vectors with inserted sequences in the E1 region are usually 
linked to a strong promoter such as the MLP. A typical construct designed 
for high level expression of a sequence in a deleted E1 region may 
encompass the MLP, sequences from the tripartite leader at the 5' end of 
the gene to be expressed and mRNA polyadenylation signals at the 3' end. 
Constructs of this kind have been shown to enhance the amount of 
expression as well as the stability of the mRNA (reviewed in Graham and 
Prevec, 1992). 
4 1 
The E3 region is non-essential for viral growth and replication of 
Ads. Therefore, deletions can be made in this area to further increase the 
amount of exogenous DNA which can be incorporated into the viral genome. 
However, the deletions. made in this area cannot extend into sequences 
laying on either side of the E3 which code for structural proteins. A 
deletion within the E3 region can be up to 2Kbp without compromizing 
viral growth . With the development of extensive restriction endonuclease 
maps (Broker et al., 1984; Tooze, 1981), deletions in the E1 and E3 regions 
can be made using recombinant DNA techniques. With deletions in the E1 
and E3 regions of the viral genome up to 7-8Kbp of exogenous DNA can be 
added. Haj-Ahmad and Graham (1986) developed an AdS vector containing 
a deletion in the E1 and E3 regions with the capacity to accept 7.SKbp of 
foreign DNA. 
2.11.1. The use of Ads as transducing viruses 
Ads have become increasingly popular for their use as transducing 
viruses mainly because they do not require target cell replication for 
transfer and expression of exogenous genes. Therefore, they are good 
candidates for in vivo gene delivery in slowly replicating cells such as 
hepatocytes and endot~elial cells for which gene delivery and expression 
was virtually impossible. Other characteristics which make Ads 
attractive transducing agents are: they can be engineered to accept up to 
7.SKbp of exogenous DNA, there is no association of human malignancy 
with Ad infection, and live Ads have been safely used before as a human 
vaccine (reviewed in Horwitz, 1990). 
Studies are now showing the potential use and safety of Ads as a 
tool to be used for somatic gene therapy of pulmonary diseases such as 
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cystic fibrosis. The aim of somatic gene therapy for cystic fibrosis is the 
introduction of the therapeutic gene (ie . cystic fibrosis transmembrane 
conductance regulator or eFTR) into respiratory epithelium . Ads seem to 
be good candidates fur this delivery for several reasons: they have a 
normal tropism for respiratory epithelia, they are capable of infecting 
non-proliferating cells and they have been shown to successfully transfer 
the cDNA of the eFTR gene in vivo in many animal species (Rosenfeld, 
1991; 1992, Li et aI, 1993). In vitro studies have shown the delivery and 
expression of reporter genes such as lacZ and the gene encoding for the 
enzyme luciferase to a variety of different cell types by the use of an Ad 
with the gene in place of the normal E1 coding sequences (Engelhardt e t 
al., 1993, Li et al., 1993, Rich et al., 1993, Bout et al., 1994). 
The first report of administration of a recombinant Ad to humans 
involved an E1 deficient Ad encoding eFTR. The recombinant Ad2 was 
administered to the nasal airway epithelium of 3 individuals with cystic 
fibrosis. The transfer of the eFTR was successful and alleviated 
symptoms experienced by the three patients (Zabner et al., 1993). 
The possibility of using recombinant Ad vectors to transfer genes in 
vivo has been investigated extensively using animal models. Reporter 
genes such as those encoding for B-galactosidase and a-1-antitrypsin 
have been successfully transferred and expressed in a variety of cell 
types using an adenoviral vector as the vehicle of transport. In vivo g e n e 
delivery and expression have been successfully accomplished in 
hepatocytes (Jaffe et al., 1992; Li et al., 1993), cells of the central 
nervous system (Bajocchi et al., 1993; La Salle, 1993), malignant cells 
(Brody et al., 1994), endothelial cells (Rosenfeld et al., 1991; Lemarchand 
et al. 1993). 
43 
2.11.2. The use of Ads for live recombinant vaccines 
The use of Ads as live recombinant vaccines is also receiving a lot 
of attention. Recombinant Ads containing a cloned gene coding for a 
foreign antigen offer many advantages. Such vaccines are valuable 
because they would be relatively cheap, easy to administer and they would 
provide long lasting immunity. 
Ad5 recombinants carrying inserts of HSV, VSV and rabies 
glycoprotein coding sequences in the E3 region have been shown to raise 
neutralizing Ab in rhesus monkeys, cows, pigs, dogs, foxes, skunks, 
racoons and mice (reviewed in Graham and Prevec, 1992). Ad vectors have 
been constructed that express the gene for various glycoproteins including 
those of the herpes virus (Johnson et al., 1988), hepatitus B virus (Morin 
et al., 1987), human immunodeficiency virus type 1 (Dewar et al., 1989), 
vesicular stomatitis virus (Schneider et al., 1989), rabies virus (Prevec e t 
al., 1990), and the respiratory syncytical virus (Collins et al., 1990; Hsu 
et al., 1991). Glycoprotein gene inserts are primarily driven by the E3 
promoter or the MLP. Expression in all of the above cases was enough to 
elicit the production of neutralizing Ab to immunize the organism against 
subsequent challenge with the antigen. 
2.12 Objectives of this investigation 
The objectives of this study were: 
(1) To make a precise deletion in the E3 region of BAV2 . 
. -(2) To insert the thymidine kinase (tk) gene of HSV-1 into the deleted 
E3 region. 
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(3) To reconstruct the BAV2 genome containing the tk in the deleted E3 
region. 
(4) To rescue a mutant virus containing tk in the deleted E3 region. 
(5) To sequence the putative E4 region and analyze the open reading 
frames of this region . 
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CHAPTER 3: MATERIALS AND METHODS 
3 . 1 Bacterial Strains 
Escherichia coli strain OH5a (BRL) was used for all recombinant 
plasmid engineering. 
3.1.1 Propagation and Maintenance of Bacterial Cultures 
Bacteria were grown in sterile Luria broth (LB; 10% Bacto-tryptone, 
[Oifco]; 5% Bacto-yeast extract, [Oifco]; 10% NaCI, [Sigma], pH 7.0). The 
bacteria were inoculated into an appropriate volume of LB containing 
appropriate antibiotics fo r selection. They were then placed into a 37°C 
shaking water bath (Gyrotory Water Bath Shaker; Model G76) overnight. In 
order to colony purify the bacteria, the overnight culture was streaked 
onto LB agar plates containing the appropriate antibiotic. For short term 
storage, the plates were placed in 4°C and for long term storage, . 1 ml 
aliquots were stored in 15% glycerol (Fisher) at -20°C. 
3.1.2 Transformation 
Transformation was carried out as described by Sambrook et al. 
(1989). Overnight culture of bacteria were diluted 1:100 into LB medium 
and grown at 37°C to an 00600 of 0.3 to 0.4. The culture was then 
aliquoted into sterile polypropylene tubes and centrifuged at 3000 rpm 
(1100xg; IEC Centra-7R) for 15 minutes at 4°C. The cell pellets were then 
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resuspended in 2Sml of ice-cold transformation buffer (7SmM CaCI2, 
fisher; SmM Tris.HCI, [Sigma]; pH 7.6) and placed in 4°C cold room on ice 
overnight. The tubes were centrifuged again as described above and 
resuspended in 1 ml of. ice cold transformation buffer. One hundred )11 
aliquots were transferred into 1.Sml microcentrifuge tubes . 
Transforming DNA (1-10)1g) was added to the competent cells and 
incubated on ice for 30 minutes, with occasional mixing (every 10 
minutes) of the tube contents. The cells were then heat-shocked for 45 
seconds at 42°C and diluted in 900)11 of SOC media (2% bacto-tryptone, 
0.5% yeast extract, 10mM NaCI, 2.5 mM KCI, 10mM MgCI2, 10mM MgS04 and 
20mM glucose). One hundred )11 aliquots were then plated on LB agar 
plates containing the appropriate selective antibiotic. The plates were 
incubated at 37°C overnight to obtain transformant colonies. 
3.1.3 DNA ligation 
DNA ligations were carried out either overnight at 16°C or at room 
temperature for 2-3 hours. A typical ligation consisted of 10-S0ng of 
digested plasmid DNA, 100ng of linearized pUC19, 0.5)11 (400U/)1I) of T4 
DNA ligase, 2)11 of 10X ligase buffer (10mM MgCI2; 20mM dithiothreitol; 
SOmM Tris; 1 mM ATP; pH 7.5, supplied by NEB) and the reaction mixture 
was brought to a final volume of 20)11 with sterile water. 
3.2 Plasmid DNA preparations 
3.2.1 Extraction of plasmid DNA 
Mini-prep DNA isolations were carried out as described by Birnboim 
and Doly (1979). Transformants were inoculated into 3ml of LB 
containing the appropriate antibiotic. In this study, ampicillin (25-
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SO).1g/ml) was used. The cultures were then incubated at 37°C in a 
shaker-water bath overnight. The culture was then collected into a 1.Sml 
microcentrifuge tube and centrifuged for 20 sec at 12,000 rpm 
(12,OOOxg). The resul.ting pellet was resuspended in 100).11 of lysozyme 
solution (10mM EDTA, SOmM glucose, 2SmM Tris.HCI, pH 8.0) that 
contained 2mg/ml lysozyme (Sigma). The tube was then incubated on ice 
for 20-30 minutes followed by the addition of 200).11 of alkaline SDS (0.2N 
NaOH, and 1.0% SDS) at room temperature for is minutes or until the 
solution became clear. One hundred and fifty ).11 of 3M NaAc (pH 4.8) was 
added and the sample was then incubated on ice for a further 30-45 
minutes. The sample was centrifuged for 5 minutes at 12,000 rpm and the 
supernatant was collected into a fresh sterile 1.Sml microcentrifuge tube. 
Two volumes of ice-cold 95% ethanol was added to the supernatant and 
the resulting solution was mixed and incubated at -20°C for 20-30 
minutes. The sample was centrifuged at 12,000 rpm for S minutes and the 
resultant DNA pellet was resuspended in 300).11 of autoclaved distilled 
water and ethanol precipitated again. The resulting pellet of DNA was 
dried at 37°C and resuspended in TE buffer (10mM Tris, 1 mM EDT A; pH7.S) 
or sterile distilled water. 
3.2.2 Large scale plasmid DNA extraction and purification 
For a large scale plasmid DNA extraction, bacterial transformants 
were grown overnight in SOOml of LB at 3rC in a shaker-water bath. The 
extraction of plasmid DNA was carried out according to the procedure 
outlined above for the mini-prep DNA isolation, except that the bacterial 
culture was centrifuged at 4000 rpm (1900xg) for 10 minutes and the 
pellet was resuspended in 10ml of lysozyme solution, followed by the 
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addition of 20m I of alkaline-SDS and then 15ml of NaAc pH 4.8. The 
resultant DNA pellet was resuspended in 1 ml of TE buffer or sterile 
autoclaved water. 
The plasmid DNA was purified by using a cesium chloride (CsCI) 
gradient using the procedure taken from Sambrook et al. (1989). For every 
ml of DNA solution, 1 g of CsCI was added. This was then mixed gently 
until the solid dissolved. An aliquot of 0.8ml of ethidium bromide (EtBr; 
10mg/ml, Sigma) was added to every 10ml of DNA/CsCI solution. The 
final density of the solution (by weight measurement) was always 
between 1.55-1.59 g/ml. The solution was centrifuged in 3ml Beckman 
Quick-Seal centrifuge tubes and centrifuged in the Beckman TL-100 
ultramicrocentrifuge at 65,000 rpm (179,000xg; rotor SN1533) for 20 
hours at 22°C. After centrifugation the red band could be visualized using 
UV light. The band was then removed using a sterile syringe and the EtBr 
was removed by a series of sequential extractions with isoamyl alcohol. 
The band was placed in a fresh sterile tube and an equal volume of isoamyl 
alcohol was added and mixed. The top layer was removed and again an 
equal volume of isoamyl alcohol was added and mixed. This procedure was 
then repeated until the pink colour had disappeared from both the lower 
aqueous phase and the upper organic phase. Any residual esCI was 
removed from the DNA with the addition of 6 volumes of sterile 
autoclaved water and the DNA was precipitated out of solution with the 
addition of 3 volumes of ice-cold 95% ethanol. The sample was left in 
-20°C for no longer than 10 minutes and centrifuged. The DNA pellet was 
resuspended in TE buffer or water. 
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3.2.3 Restriction enzyme digestion and analysis 
The enzymes used during this study (purchased from Promega, 
Boehringer Mannheim or New England Biolabs) were used according to the 
manufacturer's instructions. Digestions were usually set up for 4-16 
hours at 37°C, unless otherwise specified by the manufacturer. A typical 
digestion consisted of 10).11 of DNA (1-10).1g of DNA), 2).11 of 10X buffer and 
0.5).11 of enzyme (20Uf).1I). The reaction mixture was then brought to a 
final volume of 20).11 and placed at the appropriate reaction temperature 
(usually 37°C). 
Once samples were digested, the fragments generated could be 
visualized using agarose gel electrophoresis . Five).11 of loading buffer 
(20% glycerol, 2% SDS, 0.05% bromophenol blue) was added to the samples 
and they were loaded into the wells of a 0.9% agarose gel. The fragments 
were then electrophoretically separated at 1-10 V fcm in TAE buffer 
(40mM Tris, 20mM acetic acid, 1 mM EDTA; pH B.O). When the loading 
buffer had migrated a sufficient distance for the separation of the DNA 
fragments, the gel was then stained with EtBr (0.5).1gfml) for 10-30 
minutes. The gel was then illuminated using a UV transilluminator and 
photographed using a Polaroid Land camera with Polaroid type 57 film. 
The sizes of the DNA fragments were graphically estimated using the 
lambda-Hindlll digest (N.E.B) as a molecular weight marker. 
3.3 DNA sequencing 
The DNA sequencing of the EcoRI 0 fragment was carried out using 
the dideoxy nucleotide (ddNTP) chain termination protocol described by 
Sanger et al. (1977). The "Sequenase Version 2 Kit" (United States 
Biochemicals) was used and reactions were set up according to the 
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supplier's recommendations. Plasmid DNA was first denatured by adding 
one-tenth the volume of 0.2M NaOH, 0.2mM EDTA and incubating 1 hour at 
37°C. Then the sample was neutralized with the addition of one-tenth of 
the volume of 3M NaAc pH 4.B on ice. The denatured DNA was then 
precipitated by adding 2 volumes of ice-cold 95% ethanol and centrifuging 
in microcentrifuge for 2 minutes. The concentration of the resulting 
siflgle stranded DNA was determined using a spectrophotometer, more 
specifically by its absorbance at 260nm. (1 OD unit is equal to 
approximately 35119 of ssDNA/ml). Approximately, 3-5119 of denatured 
DNA was annealed to 5-9ng of a 16-mer primer in 10111 of 1 X Sequenase 
buffer (200mM Tris.HCI, (pH 7.5), 100mM MgCI2 and 250mM NaCI). Primers 
were either universal (pUC19 specific sequences adjacent to the multiple 
cloning site) or they were custom synthesized by Vetrogen Corp. (London, 
Ontario). Annealing was carried out at 65°C for 2 minutes, followed by 
gradual cooling to 30°C over a time period of approximately 30 minutes. 
Primed DNA synthesis was initiated with the addition of 611M of . DTT 
(dithiothreitol), 0.211M of each of the dNTPs (dCTP, dGTP, dTTP and [a-
35S]-dATP) and 3.25 units of Sequenase Version 2.0 T7 DNA polymerase. 
Following primer extension at room temperature for 5 minutes, synthesis 
was resumed in the presence of additional dNTPs and one ddNTP. An 
aliquot of 3.5111 of the reaction mixture was added to each of the four 
sequenase termination mixtures (BOI1M of each of the four dNTPs, BI1M of 
one of the dideoxy-NTPs, 50mM NaCI). The termination reactions took 
place at 40°C for 5 minutes and 4111 of stop/loading dye (95% formamide, 
20mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF) was added to 
each tube and stored at -20°C. 
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The sequencing gel is prepared in 60 ml containing the following 
chemicals: 6% Long Ranger (J.T. Baker), 8M urea and 1 X TBE (89mM Tris, 
89mM Boric acid, 2mM EDTA; pH 8.0). Approximately, 500)11 of 10% 
ammonium persulfate .and 50)11 of TEMED (N,N,N',N'-tetramethylethlene 
diamine; Bio-Rad) were added to the gel solution to facilitate 
polymerization of the gel. After pre-running the gel for approximately 1 
hour, a shark tooth comb was inserted between the plates to form wells, 
where the samples were loaded. The sequencing reactions were then 
heated to 75-80°C prior to loading the gel and 2.5)11 was loaded into each 
well. Electrophoretic separation was carried out at a constant current of 
1.25A/cm in 0.6X TBE buffer for 1.5-2 hours. Gels were lifted off the 
glass plates by adsorption to 3mm Whatman filter paper, covered with 
plastic wrap, and vacuum dried at 80°C for 20 minutes in a Bio-Rad model 
583 gel drier. Dried gels were then exposed to Kodak X-OMAT X-ray film 
for 72 hours for the 35 8 labelled samples. 
3.4 Cell line 
Madin-Darby bovine kidney (MDBK) cells were grown and maintained 
in 150mm plates in a-minimum essential medium (cx-MEM) supplemented 
with 10% fetal bovine serum (FB8; Gibco Laboratories), 0.29/lg/ml L-
glutamine, 0.225% sodium bicarbonate and 1.5% antibiotic~antimycotic 
(10,000 units/ml penicillin, 25/lg/ml amphotericin Band 10,000 )1g 
streptomycin; Gibco Laboratories). The cell line was maintained at 37°C 
incubator at constant atmospheric pressure in a C02 incubator. 
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3.5 Viral strain propagation 
Semiconfluent 60mm dishes of MDBK cells were infected with 
approximately 1 ml of BAV2 (-107 pfu/ml) and maintained in aMEM 
supplemented with 5% .FBS. Infected cells were left at 37°C in the C02-
incubator until approximately 80-90% cytopathic effect (cpe) was 
observed. The viral DNA was isolated via Hirts extraction (Hirts, 1967). 
3.5.1 Hirts extraction 
Once maximum CPE of infected cells was observed, the viral DNA 
was isolated as described by Hirts (1967) and modified by Haj-Ahmad and 
Graham (1986) . Approximately, .75-1 ml of lysing buffer (0.01 M Tris; 
0.01 M EDTA;.4% Sodium dodecyl sulphate (SDS); pH 8.0). with 1 X Pronase 
(20X stock; 10mg/ml in 0.01 M Tris, pH 8.0) was added directly to the 
plates and incubated for 2-3 hours at 37°C, followed by extraction with 
phenol :chloroform:isoamyl alcohol (25:24:1 v/v). The aqueous phase was 
collected into a fresh tube and the DNA was precipitated with the addition 
of 2 volumes of ice-cold 95% ethanol and incubated at -20°C for 15 
minutes followed by centrifugation for 5 minutes in the microcentrifuge. 
The ethanol was aspirated and the DNA pellet was dried at 37°C for 5-1 0 
minutes. The pellet was then resuspended in an appropriate volume of TE 
buffer on ice and stored at -20°C. 
3.5.2 Plaque-assay 
A tenfold serial dilution using pooled virus in PBS++ was used for 
the assay. One hundred JlI aliquots of 10-3 , 10-4 and 10-5 dilutions were 
used to infect 60mm plates containing a monolayer of MDBK cells, plated 
at 1 X1 06 cells/plate. The infection was initiated by removing the 
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medium from the plates and subsequently adding 0.1 ml of the virus onto 
the plates. After 1-2 hours incubation at 37°C, the cells were overlayed 
with 10ml of 1:1 mixture of Noble Agar (2%) and 2X MEM. Prior to the 
overlay, the noble agar and 2X MEM were brought to 42°C and mixed. Once 
the agar solidified, the plates were placed at 37°C in the C02 incubator 
until plaques appeared. Each plaque contained the progeny of a single 
virus and made it possible to obtain a population of genetically identical 
viruses. 
Once plaques appeared (10-12 days), each individual plaque was 
picked using a sterile pipet and placed in a sterile 4ml glass tube in 1 ml 
of PBS++. The plug was then mixed by pipetting up and down using the 
pipet. Then 100).!1 of this plaque-purified virus was used to infect cells 
as described before. The viral stocks were stored at 4°C and long term 
storage was in 10% glycerol at -20°C. 
3.6 Infection of mammalian cells with BAV2 and subsequent 
transfection with plasmid DNA 
Transient transfections were carried out by using calcium 
phosphate-DNA precipitate formed in HEPES (Graham &van der Eb 1973). 
Plasmid DNA purified by a CsCI/ethidium bromide density gradient 
(Sam brook et al. 1989) was dissolved in 0.1 X TE buffer (1 mM Tris, 0.1 mM 
EDTA; pH 8.0) at a concentration of 1 ).!g/).!1. The following solution was 
made using sterile conditions: (442.S).!1 TE Buffer, S).!l of plasmid DNA 
(1 ).!g/).!l), 2.S).!1 of carrier DNA (2S).!g), and SO).!1 of 2.SM CaCI2. This SOO).!1 
solution was then added slowly to an equal volume of HEPES (N-2-
hydroxyethypiperazine-N'-2-ethanesulfonic acid) while bubbling with a 
sterile pipet. This mixture was then incubated at room temperature for 
30 minutes and subsequently SOO).!1 was added to each 60mm dish 
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containing Sml of a-MEM supplemented with S% fetal bovine serum (Gibco) 
and a cell density of 1 x1 OS/plate. After 4 hours of incubation at 37°C, 
the medium was removed and Sml of fresh medium was added. The plates 
were subsequently incubated at 37°C. 
3.7 Southern blot and hybridization 
Southern blotting and hybridization with a radio labelled probe were 
carried out according to Southern (197S) as modified by Ausubel et al., 
(1992). 
3.7.1 Transfer of DNA to nitrocellulose membrane 
Viral DNA was digested overnight in approximately S0l11 followed by 
the addition of Sill of loading buffer. The sample was then separated in a 
0.8% agarose gel, with the appropriate molecular weight markers and 
controls. The gel was stained with O.Sl1g/ml EtBr and photographed. The 
gel was then placed in SOOml of 0.2N HCI for approximately 10 minutes, 
making sure that the gel was completely covered and periodically rocked. 
The gel was then washed several times with distilled water and placed in 
denaturing solution (1 M NaCI/O.SM NaOH) for 2 X 1S minutes. This ·. was 
followed by 2 X 1S minute incubation in a neutralization solution (1 M 
N H40Ac). During incubation, a nitrocellulose membrane (Dupont) was cut 
to fit the gel and then placed on top of distilled water until it became 
saturated, followed by an incubation period of 5-10 minutes in 20X SSC. 
Two pieces of 3mm Whatman paper were cut slightly smaller than the gel 
and a wick was prepared by cutting one piece of 3mm Whatman 
approximately 2 cm wider than the width of the gel. The wick was placed 
in an agarose gel container and saturated with 6X SSG. The gel was 
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positioned on top of the wick with the nitrocellose membrane placed right 
on top of the gel. The two pieces of 3MM Whatman filter paper were then 
placed on top of the membrane, so that the paper didn't overhang the 
membrane. A 2-3cm thjck stack of paper towels was then placed on top of 
the Whatman filter paper along with a gel tray and 0.2-0.4 kg of weight. 
The ends of the tray were covered with plastic wrap and the DNA was 
allowed to transfer to the membrane overnight. 
After the transfer was complete, the nitrocellulose membrane was 
dried at room temperature. The DNA was fixed onto the membrane by 
exposing the side of the membrane carrying the DNA to a source of UV 
irradiation (2S4nm) using a UV Stratalinker 1800 (Stratagene). 
3.7.2 Prehybrization, Hybridization and Washing 
Prehybrization was carried out at 68°e. Essentially, the 
nitrocellulose membrane was placed in a solution containing 6X sse, SX 
Denhardt's reagent (SOX Denhardt's contains 1 % of each of the following: 
Ficoll [Pharmacia], polyvinylpyrrolidone, bovine serum albumin [Sigma]), 
0.5% SDS and 1 OO~g of denatured herring sperm DNA for approximately 1 
hour. The volume of the pre hybridization solution used was approximately 
0.2 ml for every square centimeter of nitrocellulose membrane. 
After prehybridization, the solution was completely removed and 0.2 
ml of the hybridization mixture was added for every square centimeter of 
nitrocellulose membrane. The hybridization solution used consisted of 6X 
sse, 0.5% SDS, 1 OO~g of denatured herring sperm DNA. The radiolabelled 
probe was then added to the hybridization mixture and the hybridization 
was allowed to proceed for 2 hours at 68°e. 
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After hybridization the nitrocellulose membrane was washed for 15 
minutes at 68°C by replacing the hybridization solution with 6X SSC;O.5% 
SOS. The membrane was then washed a second time by replacing the first 
wash with 1 X SSC;O.5%SOS at 68°C. 
When the washing of the membrane was complete, the membrane 
was removed and dried by placing it on Whatman paper. The membrane 
was then covered with a piece of plastic Saran wrap and exposed to X-ray 
film as previously described. The DNA could usually be detected after 
16-24 hours of exposure at -70°C with a Cronex intensifying screen. 
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CHAPTER 4: RESULTS 
This project was multifaceted and proceeded in a series of steps to 
reach the final objective. The starting plasmid was pEA48 (supplied by 
. Kirsty Salmon) which contains the BAV2 EcoRI A fragment and the E3 
region (refer to Figure 30 for EcoRI map of BAV2). First, pEA48 was used 
as a template for subcloning which was necessary to make the deletion 
within the E3 region feasible. Secondly, a precise deletion was made 
within the E3 sequences of the BAV2 genome and a reporter gene (tk) was 
inserted. Thirdly, the BAV2 genome was reconstructed in recombinant 
plasmids which were used to facilitate homologous recombination with 
the wild-type (wt) BAV2 genome in MDBK cells. Hybridization techniques 
were then used to detect the presence of tk sequences. Finally, in order 
to understand the poor growth rate of BAV2 in MDBK cells, the E4 region of 
BAV2 was cloned and sequenced. The resulting sequence and ORFs were 
then compared to known Ad E4 sequences and proteins. 
4.1 Construction of the recombinant BAV2 plasm ids 
During this study, 9 new recombinant BAV2 plasmids were 
constructed and analyzed using restriction enzyme digestions. The 
resulting fragments were electrophoretically separated on a 0.9% agarose 
gel along with a sample of a molecular size marker (lambda phage DNA 
digested with Hindlll). The size of the fragments were determined using a 
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standard curve constructed from the distance migrated versus the known 
size of the fragments of the molecular size marker. The sizes of the 
fragments generated from these digestions were then compared to the 
expected sizes as determined from the physical restriction enzyme map 
predicted for each plasmid. Of the 9 new recombinant BAV2 plasmids 
constructed, 2 are subclones of pEA48 and 5 are of various sizes 
containing a precise deletion within the E3 region. Of these 5 plasmids, 2 
contain a reporter gene (tk) in place of the E3 region. The remaining two 
recombinant plasmids contain the right and left end of the BAV2 genome 
cloned into the vector pUC19. 
4.1.1 Subcloning of BAV2 genome 
The plasmid pEA48 was chosen as the starting plasmid due to the 
availability of an extensive restriction enzyme map for this plasmid 
(Salmon, 1993). Two plasm ids were subcloned: pSE1 and pPE1. The 
strategy for the construction of pSE1 is diagrammatically represented in 
Figure 8. The restriction endonuclease Sail cuts pEA48 in two places. 
Shotgun ligation followed by transformation and subsequent screening 
produced the plasmid pSE1 (Figure 9). This plasmid was then used in a 
similiar strategy (digestion followed by shotgun ligation) to construct the 
plasmid pPE1 (Figure 10) 
4.1.1.1 Restriction enzyme analysis of pSE1 and pPE1 
The plasmid pSE1 containing from 65.2 to 90.5 map units of the 
BAV2 genome was digested with the following enzymes: EcoRI, Pstl, Sail, 
Sall+Pstl, and EcoRI+Pstl (Figure 9). EcoRI and Sail each cut the plasmid 
only once therefore generating one band with a size of 10.9Kbp (lanes 3 & 
Hindlll( 1603~2) Scal(17524) 
Sphl( 16026) 
Psti(16020) 
Sall(16014) 
BamHI( 16005 
KpnJ( 16002)----=-1 
EcoRI(15995)A 
( 42.57.) 
HindllJ(8536) 
SphJ(8630) 
Psll(8524) 
Sall(8618) 
(65.2%) 
pEA48 
18.3Kbp 
1 . Sail 
PslJ(4751 
2. Ligation 
3. Transformation 
EcoRJ(396) 
(90.57. ) 
pSEl 
10.9Kbp Scal(2996 
Figure 8: Strategy for the deletion of the fragment between 
SaA(65.2%) and SaA in the mUltiple cloning site in pUC19. 
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(A) 
(8) 
Kbp 
Hi ndll I (8636) 
Sphl(8630) 
Psll(8624) 
Sall(8618) 
(55.2%) 
EcoRI(396) 
(90.5%) 
pSEl 
10.9Kbp Scal(299€ 
Figure 9 : (A) Photograph of a 0.9% agarose gel stained with ethidium 
bromide. Lane 1 is a lambda marker (HincJ.1I 
digest). Lane 2 represents the uncut plasmid pSEl and 
lanes 3-7 are pSEl digested with EcoRl, Pstl, SaA, SaA and 
Pstl and EcoRI and Pstl, respectively. 
(8) Restriction enzyme map of the plasmid pSE 1 . 
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Hind111(B636) 
Sphl(B630) 
Psll(B624) 
Sall(B61B) 
(65.2") 
Sphl(4757) 
Psll(4751l 
(77.17.) 
Scal(6374) 
Ampr 
pSEl 
10.9Kbp 
1. Pstl 
2. Ligation 
Scal(2996 
3. Transformation 
pPEl 
7.0Kbp 
E3 
EcoR1(396) 
(90.570) 
Figure 10: Strategy for the deletion of the fragment between 
Pstl (77.1 %) and Pstl in the multiple cloning site of pUC19. 
6 1 
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5, respectively). Pstl generated two bands (lane 4); 7.0Kbp and 3.9Kbp. 
Digestion with Sail and Pstl together generated the expected two bands 
(lane 6); 7.0Kbp and 3.9Kbp, whereas a double digestion with EcoRI and 
Pstl generated 3 bands __ (lane 7); 4.3Kbp, 3.9Kbp, and pUC19, 2.7Kbp. The 
construction of pSE 1 was confirmed using restriction enzyme digestions 
and the restriction map of pSE1 is shown in Figure 9B. 
pPE1 was shown to contain the BAV2 genome spanning from 90.5 to 
77.1 map units by digesting the plasmid with Pstl, EcoRI and EcoRI+Pstl 
(Figure 11 A). The enzymes Pst! and E coRI each cut the plasmid once 
(Figure 11 B), therefore generating a band of 7Kbp in size (lanes 3 & 4). 
When pPE1 was digested with both EcoRI+Pstl, 2 bands were generated; a 
fragment 4.3Kbp and pUC19; 2.7Kbp (lane 5). The construction of pPE1 
enabled us to proceed to the next step involving the deletion of the E3 
region. This plasmid contains two unique restriction enzyme sites, Pstl 
and Seal, which flank the E3 region and made the deletion of the E3 region 
feasible. 
4.1.2 Deletion of the E3 region 
The availibility of the nucleotide sequence of the BAV2 E3 region 
(Esford,1994) enabled a precise deletion (1800bp) to be made within this 
region. The strategy involved digesting pPE1 completely with Pstl + Seal 
and ligating in the presence of a synthetic linker (Procyon Biopharma Inc. 
London, Ontario) with compatible sticky ends for Pstl and Seal. The 
synthetic linker contained a multiple cloning site with several unique 
restriction enzyme sites designed to facilitate the insertion of foreign 
DNA sequences in recombinant plasm ids. The deletion of the E3 region 
was confirmed by both restriction enzyme analysis and by sequencing 
(A) 
(8) 
Kbp 
23.1- , 
~:~= 
4.3-
1 2 3 4 5 
Scal(6374) 
Hindlll( 4763) 
Sph I (4757)---::7'\ 
Pstl(4751 ) 
(77.I%) 
pPEl 
7.0Kbp 
Figure 11 : (A) Photograph of a 0.9% agarose gel stained with ethidium 
bromide. Lane 1 is a lambda marker (Hincllli digest). 
Lane 2 is uncut pPE1 and lanes 3-5 are pPE1 digested 
with Pstl, EeaRl and EeaRl+Psti, respectively. 
(8) Restriction enzyme map of the plasmid, pPE1. 
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(Figure 16A & B). The sequence analysis revealed that the deletion was 
precisely made between Pstl(77.1 m.u.) and Scal(82.5m.u.) and the multiple 
cloning site was successfully inserted. 
4.1.2.1 Restriction enzyme analysis of pd1E3-1 
The confirmation of the construction of the plasmid, pd1E3-1 
involved the use of several restriction enzyme digestions: EcoRI, Pstl, 
Ba mHI and Xhol (Figure 13A). Each of these restriction endonucleases 
digest pd1E3-1 only once, generating 1 band approximately 5.3 Kbp in size 
(lanes 3-6, respectively). The physical restriction enzyme map of pd1E3-1 
is shown in Figure 13B. 
4.1.3 Reconstruction of BAV2 genome in recombinant plamids 
The next step following the deletion of the E3 region involved 
reconstructing the left end of the BAV2 genome in recombinant plasmids. 
This reconstruction was required to provide a large area for homologous 
recombination to occur between the plasmid DNA and the wtBAV2 genome 
in subsequent steps of this project. Two plasmids pd1E3-3 and pd1E3-4 
were constructed using shotgun ligation strategies as oulined in Figure 14 
and 17, respectively. 
4.1.3.1 Restriction enzyme analysis of pd1E3-3 and pd1E3-4 
pd1E3-3 was confirmed to contain from 65.2-90.5 map units (E3 
deleted) of the BAV2 genome using the following restriction enzyme 
digestions: BamHI, BamHI + Sail, EcoRI, Pstl, EcoRI + Kpnl and EcoRI+BamHI 
(Figure 15A). BamHI and EcoRI each cut pd1E3-3 once to generate 1 band of 
approximately 9.1 Kbp (lanes 3 & 5, respectively). When pd1E3-3 was 
EcoRI(396) 
(90.57.) 
Scal(6374) 
Hindlll(4763) 
Sphl(4757) 
PsU(475 J) 
(77.17.) 
Hind" /(3040) 
Sphl(3034) 
pPE1 
7.0Kbp 
1. Pstl, Seal 
2. Linker 
3. Ligation 
4. Transformation 
pd1E3-1 
5.3Kbp 
Pstl(302B) BamHI(302;:;2~) ==~~ .... - ... " 
Clal(3016) 
Figure 1 2: Strategy for the deletion of the E3 region 
between Pst! (77.1 %) and Seal (82.5%) and the 
insertion of a linker(Seal, Kpnl, Xhol, Clal, BamHI, 
Pstl). 
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(A) 
(8) 
Kbp 23.1-9.4-
6.6-
4.3-
Hindlll(3040) 
Sphl(3034) 
, 2 3 4 5 6 
pd1E3-1 
S.3Kbp 
Pstl(3028)=-~~"_"'~ 
BamH I (3022) 
Clal(3016) 
Xhol(3010) 
Kpnl(3004) 
Scal(2996) 
Figure 13 : (A) Photograph of a 0.9% agarose gel stained with ethidium 
bromide. Lane 1 is a lambda marker (Hindlll digest). 
Lane 2 is uncut pd1E3-1 and lanes 3-6 are pd1E3-1 digested 
with feaR I , Pstl, BamHI and Xhal, respectively. 
(8) Restriction enzyme map of the plasmid, pd1E3-1 . 
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HindII1(30<10) 
pd1E3-1 
S.3Kbp 
Sphl(3034) 
Psll(3028)-~~""_"'~ 
BamHI(3022) 
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Hindlll(6913) 
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(652~) 
Hind111(8636) 
Sphl(8630) 
Ps1l(8624) 
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(652~) 
2. Ligation 
pSEl 
10.SKbp 
1 . Pstl 
3. Transformation 
IECOR !(396) (905~) 
.--,._-./.',",-
Amp r 
pd1E3-3 
9.1 Kbp 
Scal(2996: 
Kpnl(3004) 
Xhol(3010) 
Figure 14: Strategy of the reconstruction of the right end of 
BAV2 by digesting pSE1 and pd1E3-1 with Pstl and ligating. 
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Scal(2996 
(A) 
(8) 
Kbp 23.1-
~:t= 
4.3-
Hindlll(6913) 
Sphl(6907) 
Pstl(6901 ) 
Sall(6895) 
(55.2%) 
'234567 8 
Scal(8522) 
Ampr 
pd1E3-3 
9.1 Kbp 
EcoRI(396) 
(90.5%) 
Scal(2996 
Kpnl(3004) 
Xhol(3010) 
Clal(3016) 
BamHI(3022: 
Pstl(3028) 
Figure 15 : (A) Photograph of a 0.9% agarose gel stained with ethidium 
bromide. Lane 1 is a lambda marker (Hindlll 
digest). Lane 2 represents the uncut plasmid pd1E3-3 and 
lanes 3-8 are pd1E3-3 digested with BamHI, BamHI and SaA, 
fcoRI, Pstl, fcoRI and Kpnl and fcoRI and BamHI. 
(8) Restriction enzyme map of the plasmid pdIE3-3. 
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Hindlll(6913) 
Sphl(6907) 
Pstl(6901) 
Sall(689S) 
(65.2%) 
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Xhol(3010) 
Clal(3016) 
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Figure 16: A photograph of a sequencing gel (6% Long Ranger) 
showing the nucleotide sequence of the multiple cloning site in the 
deleted E3 region. Panel 8 shows the restriction enzyme map and 
36 bp corresponding to the restriction enzyme sites within the MCS. 
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Hindlll(6913) 
5phl(6907) 
Pstl(690 1) 
5a11(6B9S) 
(652~) 
Arnpr 
pd1E3-3 
9.1 Kbp 5ca1(2996: 
Kpnl(3004) 
1 .Sall 
5cal(20 124) 
Hindlll( las 15)\ 
5phl(18509) 
Psli( 18503) 
5all( 111496) . 
5caI(13779) 
EcoRI(396) 
Kpnl(40B) 
// /BamHI(417) 
V_5all(429) 
Hindlll(12049)\ 
5phl(12043) 
Pstl( 12037) 
5all( 12031) 
(29S~) pSalA 
14.3Kbp 
2. Ligation 
3. Transformation 
5cal(2996) 
Kpn1(3004) 
Xho1(3010) 
Clal(3016) 
BamH1(3022) 
Psli(3028) 
1. Sail 
pd1E3-4 
20.7Kbp 
EcoRI( 14271) 
Noli( 14174) 
Figure 17: Strategy of the reconstruction of BAV2 genome with the 
insertion of the Sal A fragment (65.2 m.u.-29.Sm.u.). The genome now 
extends from 29.5 m.u. to 90.Sm.u. with the E3 deleted. 
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digested with BamH 1+ Sail and Pstl, 2 bands were generated in each case: 
5.2Kbp and 3.9Kbp (lanes 4 and 6, respectively). The two remaining 
digestions, EcoRI+Kpnl and EcoRI+BamHI , generated two bands: 6.5Kbp and 
2.6Kbp (lanes 7 and 8, _  respectively) . The physical restriction enzyme map 
of pd1E3-3 is shown in Figure 15B. 
The plasmid pd1E3-4 was shown to contain the BAV2 SalA fragment 
by digesting the plasmid with the following enzymes: Sail, EcoRI, BamH I 
and BamHI + EcoRI (Figure 18A), and analyzing the fragments generated. 
When pd1E3-4 was digested . with BamHI, the one expected band was 
generated at 20.7Kbp (lane 6). Both Sail and EcoRI, each recognize two 
sites within pdIE3-4, therefore generating two bands at 11.6Kbp, 9.1 Kbp 
and 13.9Kbp, 6.8Kbp, respectively (lanes 3 & 4). The double digestion with 
EcoRI+BamHI generated the expected 3 fragments: 11.2Kbp, 6.9Kbp and 
2.6Kbp (lane 5) and confirmed the orientation of the SalA fragment within 
the plasmid, pdIE3-4. The physical restriction enzyme map of pd1E3-4 is 
shown in Figure 18B. 
4.1.4 The cloning of a reporter gene (tk) in the deleted E3 
region 
The strategy to clone the tk gene of HSV in place of the deleted E3 
sequences was slightly different from those used in previous steps 
(Figure 19). The strategy involved the use of the plasmid pd1E3-4 digested 
with BamHI. BamHI generated a single band from a cut within the multiple 
cloning site. The digested pd1E3-4 was combined with Pvull digested 
tk173 and a synthesized Ba mHI linker (Procyon Biopharma, London, 
Ontario) and ligated with T 4 DNA ligase. The ligated DNA was used to 
transform competent E. coli strain DH5a. The recombinant plasm ids were 
isolated from transformed E. coli and screened for the presence of the tk 
, 2 3 4 5 6 
(A) Kbp 
(8) 
Scal(20124) EcoRI(396) Scal(2996) 
Hindlll(18515)\ 
Sphl( 18509) 
Pstl(18503) . 
Sall(18496) . 
EcoRI( 14271) 
Notl(14174) 
Clal( 12972) 
(90.5%) Kpnl(3004) 
pd1E3-4 
20.7Kbp 
Xhol(3010) 
Clal(3016) 
BamHI(3022; 
Pstl(3028) 
Sall(6895) 
Clal(6992) 
Figure 18 : (A) Photograph of a 0.9% agarose gel stained with 
ethidium bromide. Lane 1 represents a lambda (Hindlll digest). Lane 2 
represents the uncut plasmid pd1E3-4 and lanes 3-6 represent pd1E3-4 
digested with restriction enzymes SaA, EeaRI, BamHI and feaR I and 
BamH I, respectively. 
(8) Restriction enzyme map of pdIE3-4. 
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Pstl(IElS03) . 
SalJ(IEl496) 
EcoRI( 14271) 
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1 . BamHI 1 . Pvu" 
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Hindlll(20SSS) 
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SalJ(20S36) 
EcoRI(16311l 
NolJ(16214) 
pdlE3-4tkl 
22.7Kbp 
Scal(2g96) 
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Xhol(30 10) 
Clal(3016) 
BamH1(3022) 
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2. Ligation with BamHI Linker 
3. Transformation 
EcoRI(16311) 
Noll( 16214) 
Clal(15012) 
22.7Kbp 
Scal(2g96) 
Kpnl(3004) 
Xho1(3010) 
ClaJ(3016) 
BamHJ(3022) 
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6. Pstl(323S) 
Pr ~ Ps1l(407S) 
Om BamHI 
~ Psll(S06El 
Figure 19: The insertion of the thymidine kinase (tk) gene in the unique BamHI 
site. The tk gene is inserted in both orientations with its own promoter. 
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gene using restriction enzyme analysis. Out of the 250 colonies screened, 
two were found to contain the tk sequences. The plasmid, pdlE3-4tk1 
(Figure 20B) has the tk gene in the orientation parallel to the deleted E3 
sequences, whereas in ._pdIE3-4tk2 (Figure 21 B), the tk gene is in the anti-
parallel orientation. 
4.1.4.1 Restriction enzyme analysis of pdlE3-4tk1 & pdlE3-4tk 
The plasmids, pdlE3-4tk1 and pdlE3-tk2 were confirmed by 
digestion with the following restriction enzymes: BamHI, EcoRI and Sail 
(Figure 20A &21A). When both plasmids were digested with BamHI, two 
bands were generated (Figure 20A & 21 A; lane 3); a large fragment 
approximately 20.7Kbp and the tk gene, 2Kbp. Digestion with Sail 
generated a doublet in both cases; 11.6Kbp and 11.1 Kbp (Figure 20A, lane 5 
and Figure 21 A, lane 6). Unlike BamHI and Sail, EcoRI cuts within the tk 
gene and was used to confirm the orientation. EcoRI generates 3 
fragments for pdIE3-4tk1: 11.3Kbp, 6.9Kbp and 4.5Kbp (Figure 20A, lane 4), 
whereas 3 fragments differing in size were generated for pdlE3-4tk2 
(Figure 21 A, lane 4): 13.1 Kbp, 6.8Kbp and 2.8Kbp., A double digestion of 
pdlE3-4tk2 with EcoRI & BamHI generated 4 bands (Figure 21 A, lane 5): 
11.2Kbp, 7.0Kbp, 2.6Kbp and 1.9Kbp. In addition to these, a short fragment 
(120bp) is expected to be generated, however it can not be seen clearly on 
the agarose gel due to its small size. 
4.1.5 Cloning of the right and left end of BAV2 genome 
To increase the library of recombinant BAV2 plasm ids and provide 
alternative strategies for rescuing a BAV2 vector, the right and left end 
of the BAV2 genome were cloned to generate the plasmids pd1E3-5 and 
(A) 
(B) 
Kbp 23.1-
9.4 -
6.6-
4.3-
1 2 3 4 5 
Scal(22164) 
Hindlll(20555) 
EcoRI(396) Scal(2996) Kpnl(3004) 
(90.5%) Xhol(3010) 
Psll(20543) 
Sall(20536) 
EcoRI(16311) 
Noll(16214) 
Clal(3016) 
BamHI(3022) 
t Pstl( 4009) 
" &. Psll (4849) 
pdlE3-4tkl 
22.7Kbp 
Pr ~ EcoRI(494; 
o BamHI 
Pstl(5068 
Sall(8935) 
Clal(9032) 
Xhol( 10917) 
Figure 20 : (A) Photograph of a 0.9% agarose gel stained with ethidium 
bromide. Lane 1 is a lambda marker (HindJlI 
digest). Lane 2 represents the uncut plasmid, pdlE3-4tk1 
and lanes 3-5 are pdlE3-tkl digested with BamHI, feoRl, 
and SaA. 
(B) Restriction enzyme map of the plasmid pdlE3-4tkl 
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Scal(2996) 
EcoRI(396) Kpnl(3004) (90.570) 
Xhol(3010) 
Clal(3016) 
BamHI(3022) Psll(20543) Sall(20536) 
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Pr ~ Pstl( 4075) 
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Clal(9032) 
Xhol( 10917) 
Figure 21 : (A) Photograph of a 0.9% agarose gel stained with Et8r 
Lane 1 is a lambda marker (Hindtl! 
digest). Lane 2 represents uncut plasmid, pdlE3-4tk2 
and lanes 3-6 represent the plasmid digested with 
BamHI, EcoRI, EcoRI and BamHI, and SaA. 
(8) Restriction enzyme map of plasmid pdlE3-4tk2 
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pdIE1-E, respectively. However, these plasm ids were not used for any 
rescue attempts during this study. The strategy to clone the left end 
involved using Sail digested pBBSK (provided by Jeff Kormos) combined 
with San digested pEB and ligated with T4 DNA ligase (Figure 22). The 
recombinant plasmid, pd1E1-E was isolated from transformed E. coli. This 
plasmid was confirmed to contain 0-42.5m.u. of the BAV2 genome with a 
deletion in the E1 region using the following restriction enzyme analysis: 
Sail, EcoRI and Sall+EcoRI (Figure 23A). Sail and EcoRI each generated 2 
fragments: 9.6Kbp and 4.2Kbp and 7.1 Kbp and 6.7Kbp, respectively (lanes 3 
& 4). The correct orientation was confirmed by the analysis of the EcoR I 
digestion. An E co RI restriction enzyme site is situated within the 
fragment cloned in the unique Sail site. When this plasmid was digested 
with both EcoRI and Sail, 3 bands were generated: 6.7Kbp, 4.2Kbp and 
2.9Kbp (lane 5). Figure 23B is the physical restriction map of pdIE1-E. 
The strategy employed to clone the right end of BAV2 was simi liar 
to that used for the left end (Figure 24). The plasmid, pd1E3-5 was shown 
to contain 65.2 -100m.u. of the BAV2 genome with a deletion within the 
E3 region through analysis of the fragments generated from the following 
restriction enzyme digestions: EcoRI, Sail and Pstl (Figure 25A). Sail 
cuts the plasmid once, generating one band at 12.6Kbp (lane 4). EcoR I 
generates two bands: 9.1 Kbp and 3.5Kbp (lane 3), whereas Pstl generates 4 
bands: 5.3Kbp, 3.9Kbp, 2.9Kbp and a small fragment at 520bp (lane 5). The 
resulting DNA fragments from the Pstl digestion of pd1E3-5 suggested the 
presence of an additional Pstl site at approximately 99 m.u. which was 
later confirmed when the sequence of the right end was analyzed. 
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Figure 22: Strategy used in the construction of pdlEl-E from plasmids 
pBBSK and pEB. 
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Hindlll(1163B) 
PStI(11632) 
Sall(11626) 
BamHI(11614 
Kpnl(1160B) 
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(42.5%) 
PstIC 1 0497) 
1 2 3 4 5 
BamHI~ 1~~ 
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..._--..I11III;;; PVU I (49 1) 
pdlEl-E 
13.8Kbp 
Sall(7377) 
(29 .5r.) 
BamHI(3672) 
EcoRI(448S) 
Figure 23: (A) Photograph of an agarose gel stained with ethidium 
bromide. Lane 1 is a lambda marker (Hindll!) digest. 
Lane 2 is uncut pdlEl-E and lanes 3-5 represent 
pdlE l-E cut with SaA, EeoRl and SaA+EeoRI, 
respectively. 
(B) Restriction enzyme map of pdIEl-E. 
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Figure24: Strategy of the cloning of the fcoRI D fragment in 
the unique fcoRI site of pdIE3-3. The new plasmid, pd1E3-S 
now extends from SaA (6S.2m.u.) to fcoRI (1 OOm.u.). 
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Figure 25 : (A) Agarose gel stained with ethidium bromide. 
Lane' is a lambda marker (Hina11! digest). Lane 2 
is uncut pd1E3-5 and lanes 3-5 are pd1E3-5 cut 
with EcoRI, SaA, and Psti, respectively. 
(8) Restriction enzyme map of pdIE3-5. 
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4.1.6 Attempt to rescue a BAV2 E3 deletion mutant 
The strategy used involved infecting MDBK cells with wtBAV2 
followed by transfection with CsCI purified plasmid, pdlE3-4tk1 (Figure 
26). The recombinant plasmid, pdlE3-4tk1 is large enough to facilitate 
homologous recombination with the wtBAV2 genome in MDBK cells. A 32p 
labelled tk173 probe was hybridized to Hirts extracted pooled viral DNA 
that was digested with BamHI and BamHI + EcoRI. The DNA was extracted 
after the second round of infection to eliminate any residual plasmid DNA 
from the transfection. The DNA fragments that hybridized to the 32 p-
labelled tk173 probe appear as bands (Figure 27). The sizes of the DNA 
fragments were determined using a lambda Hindlll digested marker (lane 
1) and Pvull digested tk173 (lane 2). When BamHI digested viral DNA was 
probed with 32 P-Iabelled tk173 one band, approximately 2Kbp in size 
(lane 4), co-migrated with the tk gene of Pvu II digested tk173 (lane 2). 
The larger band also generated is the result of partial or undigested viral 
DNA. When the viral DNA was double digested with EcoRI and BamHI, a 
band slightly lower than 2Kbp was generated. This is expected because 
there is an EcoRI site located within the tk promoter. The sizes of the 
higher bands observed were determined to be approximately 6Kbp · and 
4.3Kbp from an agarose gel (data not shown). Therefore, it is reasonable 
to assume that these bands are a result of partially digested viral DNA. 
For example, if the BamHI digestion was incomplete and the enzyme did 
not cut some viral DNA at 82.5 m.u. (See Figure 27), then it is possible to 
obtain a 32p labelled fragment at approximately 4.4 Kbp. 
To further investigate the results represented in Figure 27, a 32 P 
-labelled tk173 probe was hybridized to Hirts extracted DNA from plaque 
purified virus that was digested with BamHI. Of the 70 plaque isolated, 4 
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Fi gure 26: Strategy used I n the at tempt to rescue a BA V2 mutant conta i n i ng a de I et i on in the E3 
region with the thymidine kinase gene In Its place. 
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Figure 27: Photograph of an autoradiogram of Hirts extracted viral 
100 
I 
DNA, digested with BamH I (I ane 4) and BamH+ fcoR I (1 ane5) 
hybridized to radioactive labelled.tk 173. Lane 1 is a lambda 
marker (Hindi I I digest), lane 2 is Pvull digested tk 173 and lane 3 
is BamHI digested cell line DNA 
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showed one band slightly higher than the tk gene from Pvull digested 
tk173 (lane 3) (See Figure 28A; marked with*). 32P-labelled BAV2 DNA 
was hybridized to the samples so that the viral DNA fragments would 
appear as bands (Figure 28B). When hybridized to the 32 P-Iabelled BAV2 
DNA, two additional fragments were apparent in every lane containing 
plaque purified viral DNA digested with BamHI. The approximate size of 
one band is 5.8Kbp, however the size of the larger band which is greater 
than 23.1 Kbp is to large to estimate. 
4.2 Sequencing of the E4 region 
4.2.1 Sequencing strategy. 
Sequencing of the E4 region started with the. plasmid, pED, which 
contains the EcoRI D fragment (90.5%-100%) of BAV2 cloned into the 
vector pUC19. Universal primers (specific for pUC19 sequences) were 
used to initiate the sequencing and custom synthesized oligonucleotides 
(Procyon Inc. London, Ont) were used to continue the sequencing of the 
entire fragment (Figure 30). Vent polymerase was used to resolve 
compressed areas. Figure 29 is the resulting nucleotide sequence from 
90.5 to 100 map units of BAV2 corresponding to the E4 region and the 
right ITR . 
4.2.2 Organization and homology of the putative E4 region 
Within the 3550 bp fragment, there are 40 ORFs capable of coding 
for polypeptides of 25 or more amino acids. A homology search of the 
nucleotide and predicted amino acid sequences using the European 
Molecular Biology Laboratory (EMBL) nucleic acid and protein data base and 
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Figure 28: (A) Photograph of an autoradiogram of plaque purified viral 
DNA, di gested with BamH I and hybridi zed to radi oact ive 1 abe 11 ed. 
tk 173. Lane 1 is a lambda marker (Hind III digest), lane 2 is 
BamHI digested ce 11 1 ine DNA, lane3 is Pvull digested tk 173 and 
the remaining lanes represent plaque purified viral DNA. 
(B) Photograph of an autoradi ogram, represent i ng the samp 1 es in 
(A) hybridized to radioactive labelled SAV2 DNA. 
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Figure 29: Nucleotide sequence of the BA V2 genome from 90.5 m.u. to 100 
m.u. Potenial "T AT A" boxes are represented in bold, as are the 
polyadenylation signals and the first ATG of 6 ORF which share identity to 
proteins encoded by the E4 regIOn of other Adenoviruses. 
100% 5' ORI NFL binding site 
CATCATCAATAATATACGGTGCATITTGTGCGTGATGACGTATACAGCGTACGTAAGGGA 
GGAGCITGCAAGCGTGGGAAACITGACCITfGAACGGGCGCGGTGAAGTGGGTIGGACAA 
CCITTGAGCATGAGGTGCTGGAATTATTGACCITTACACAGGCGGAGTTCAGTTTCGCTA 
CGTCAGTGGACTIGCCGGCAAGCCC.A..GTACTITTCCAGTCAGTGACAGTGACGCCTAAGG 
"TATA" 
GTGGAGTACATCCITfAAATACAGCAGTGACGACITfAGACTCAGCACTGCGCCTCACTC 
"cap" ORFI start 
ACAGCCAGTTTTACCATTCTGCCACTACTTAACITTAGATGCTCTTCAGClllllGTTGA 
GAGCGGCTTTGCCATCTGCTGTGCTTCCTAAGCGAGCITCTGc.A..GGAGCTGCTGGATATG 
ACTIGTGTGCTTCTACTTATGTAGAAGTTCCAGCTGGAGCAAGAGTGCTAGTTCCTACTG 
GATTAAAAATTTCAATTCCAGAAGGACATTATGGACCGTACGTCCGCGATGTCTGGGCTT 
GCTGTIACTCAGGCITfAATGTGGGAGCTGGCGTGATCGACTGCGACTACAGGGGAGAGC 
TGTTTGTATTAATTTTTAATCATGGAAACCAAAATTACCTTATTTCGCCAGGACAGCGAG 
ORFI end 
TGGACGc.A..CGTTATTATTGAAAAACTCTGACTCTGTGTGGAGTTGGACAGCATCGACGAC 
CACACTGAAAGAGGTGCTAGCGGCTTTGGGTCTACTGGA TTATA TTGGCTCCTGTTGTCA 
ATGGGGAAATTATAAAAATTTTAATTCCTTCATCITTAACTAACTCTGTGCATAGCGAAC 
GACCTCAAGA TTTTGCT ACA TCTGTGGCTTCAA TGGCTGAGTGTTGTGGCCTCTAAGCTG 
ATTATATAGCGCTCGGCAATAATGTGTTATTTAAGTICTTACTGCACTCATCAGCCAAAC 
TGTIATGTTGTAGTCCTCCCTGTTTGTAGGAGGAGCTTCAACAGATTCITTACTTACTAA 
TAATGGCGAATATGAAGAlllrllAATTAATGAGCTACAA..GAATATTTGCATGAAGCAGT 
GTTTGATTACACTCGCCTACTTGGAGAAGACATTTCCCTAGAAGACTGCAAATTTATACA 
AGTTAGCTCAGTATAA..GTTTTACATGTGGTATGATGCATTTGTCAATAAATGGTTTCTTT 
88 
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660 
720 
780 
840 
900 
960 
1020 
1080 
1140 
1200 
ORF2 start 
AAGAAAA TcrGcrGAM. ITGTITcrATCA IT AA TT ATGTT ACCAA TCAACTCGAGAAGTC 
TTTTATAGTITAcrATCAACATITAA.TGAGGAAAGTTCACAACGTTGGATTTAcrTTGTC 
TACGTTCA TCAA TTGCAGcrGCAGAG.A.GCACGGATGGGTCGCCGATcrGTGCATGAGcrT 
TTGcrTTGTGGAGAACATcrATCAAGAcrTGAGAAGGTACTTATTGACTTATAcrTTGAA 
ORF2 end 
CATGGACAATITAAACATCAAAAGTAGTGAcrATAACTGCCGCAGITcrTTATcrAATCA 
CTGCA TTGGATATGTGAAGTCACCAA.AATCATGCGACATGTTTTGcr ATGTGTTT AGAAC 
TTCCGATTcrTTGGGAGTITATTTTATGTCACCATGAAA.CTATCrlllrAA~TTATT 
TATGTAATTGCGTAGAGAITGAAATGTGCTcrGTGTATGATAAATTTTTATTACcrGATT 
ACTCCTCACTTGcrGCTAGGTGGGGCTTACATTGCCACTGTACAGATAGACAAAcrTTAC 
AATGTTTTGcrGcrAGGCGTGTCATAGAAGcrTTAGTTAAAGAGGTTTTAAAGGGCACAA 
TGTATAATCAGATGTTTTGGGATTATAGACAATTTGTA~A.CAGAGGCTTGCTGATAcrTT 
ORF3 
ATGTITGTTGGCAGTT A TT A TGTT AGA.A.GAGTTCA TTTTA TTGT AA TT AAAGTT A TITI A 
GACAAAGATGTGGAAAAAATAAGGA~GTTGCAATITGGGGAAGCAGCTTATAITAATGGC 
CTGTATAGCAATTTTATAGTGCTIATTTGCCTGcrGAGCAATTTAAcrGAGATTCAGGCA 
AATITGCGTAGGACTAGAAAGTTTCTTTTAAAAGCATTA~GTGTTGTcrAGTCGGGCCA 
AAAGTTGCT AGT AAAAAAGAAGCCCAGCGACAAAAAGA TTT AA IT AGGTTGTTT AAGTTT 
ORF4 start 
1260 
1320 
1380 
1440 
1500 
1560 
1620 
1680 
1740 
1800 
1860 
1920 
1980 
2040 
2100 
2160 
GGGTCAGCA TITGACTCAAAAGTATGT.~ TATcrTTAA. TTTCAGATGTTGTGCcrGTC 2220 
ORF3 end 
CAGGCCTACATATCAGCATAJV\ATCATTGGATATGTAGCTGCTCCGTTGTcrTGTTTACC 2280 
TTTAGcrATGAATCAAGAATITCcrATTCCGTGGAAGCATATATTGCCATCGTGGGAGTA 2340 
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CAGCCTGTIAAAAAA. IT A TITGTGTATCGCCTCTAGGTITAA.AATAGAGTGGGATGGGGA 24009 0 
ORF5 start 
TCT AGCTITAA TGGIT AGACACAA TCAGCCTIT A TIGTGGAGCGTGTGCTGTCATGA TCA 2460 
ORF4 end ORF5 end 
ACA TGAAAA T ACGITGCAAGCTTITGCA TGAGGTGTGT:KCA TGT A.A.AAGAGCTIGTGGG 2520 
TCGGGTITGAGTATAATTTAAAGTTICCATTITATAGAA.·\AATIGTAAACAAAAATTTAA 2580 
GTIITAGAATCCTGTATGAA.GGAAGTTAGTGTIAAGCGAACGATITAATATITGTGAAAA 2640 
ORF6 start 
CTAAATGGGAGATATAAGCAGGAITAGAAAGTIAAAGTITAATAAITCTGITATTTGTAG 2700 
AGGTIITACTGGGGTGTACTIAGTGTTAITITGTGATAGTTGCAATAATATGACAGAATA 2760 
ORF6 end 
TAGTGCTAGATIGTGTGCTGCAAACACTAGGGITAAGTTAGTATIAGTAGCCCAATAATT 2820 
GTGATACATITCGTIGAAACTAGTGAATATGAAAGAAGAACAAATIGATATICAGAAGTT 2880 
AACTIATAAGCCGTGTGTATGTTTATAGATGCAGCTGAAGCTGTITGTGCACACTGGACC 2940 
AAAAGGCTCAGCACCATGTTAAATCTAGAGAAGAAGTATGGCTAGTAACTAGTGAAGACA 3000 
TGATGTIITACCCTIATGAAGATAATGAATATGAACTGGATCATGAAGTGTATATICCCG 3060 
polyA 
ATGGTIATGATGTITCAGTAGTIAGCI I I I I I I I lAATTIGTATATAAAAATGAATTACA 3120 
GAGATAA TGT AA TITCTAAAA TI AGTCT AAAAA TGTACGAGTGGTCTCCAGGTATGATIT 3180 
TIATTCGACGCTGGAGAGCCAATTGTICAAATIAAACTIACGTCTCTITCAGCATGACGG 3240 
CAAAAAAAATICAGCTIGAGCCCGAAATIGAAATIGAAGTIGGACCACGAACATTTCAAA 3300 
CCCCTCAITTITAATGAAAATCTCACAGAAGTGCTITGTGTITAGAGAAGCTATIGAATT 3360 
AAGAAAGTCGAGTGTCTIAAGTITGATGTAAAATTAGA.A.TCCAGATGGATATIATGGCAT 3420 
GGGGTCTGTITCTAGTTIGAITGGTCTGCCGTATGATATATGGGGAAGAATATTCACTGC 3480 
TGTAACTICTGTGTICAGTCCTACATTITCTGTAAGTITGCCATGGTGGGAAAAGAGAAA 3540 
GGTCCTGTAA 3550 
m.u. 
kbp 0 
RFI 
RF2 
RF3 
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fcoRI 
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BAV2 fcoRI map 
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Figure 30 : The genom e of BA V2 show i ng the 1 ocat i on of the putat ive E4 
reg ion located with i n the EcoR I 0 fragm ent. Open readi ng fram es that 
were found to resemble the Ad E4 proteins are represented by the 
shaded boxes. The arrows represent the primers used for sequenc ing. 
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the FASTA program (Pearson and Lipman, 1988), revealed that six of these 
ORFs share homology to the well characterized E4 proteins of human Ads 
(Figure 30). 
In Ad2, E4 mRNAs are produced through a series of differential 
splicing of a primary transcript. It has been reported that the cap site for 
Ad E4 mRNAs (5'-TTTTTA-3') is located between 324-329 bp, whereas the 
poly(A) addition site follows the second A in the sequence 5'-CATAA-3' at 
position 3136. The only potential cap site (TTTT A) in the putative E4 
sequence of BAV2 is located at position 309 (30 bp upstream from the 
first ATG of ORF1). A possible poly(A) site (ATAAAAA) is located at 
position 3104 (288 bp downstream from the stop codon of ORF6). 
ORF1 encodes a 114 amino acid long protein which has 28.9% 
identity and 54.4% homology with the E4 14kDa protein encoded by ORF1 
of Ad2 (Figure 31 A) . The location and size of this ORF is remarkably 
similiar to the first ORF of the E4 region of Ad2 (Virtanen et al., 1 984) 
suggesting that this ORF is the first exon of the E4 transcription unit. 
Therefore, the only potential TAT A box (TAATA) is located at 256 bp, 
which is 83 bp upstream from the first ATG in ORF1 (position 339 bp). The 
78 amino acid long protein encoded by ORF2 shares 11.3% identity and 
40.2% homology (Figure 31 B) to the known Ad2 E4 13kDa protein of ORF3 
(Virtanen et al., 1984). Although this ORF appears in a similiar position, 
the protein encoded is slightly smaller than the 13kDa which may be 
accounted for by the fact that BAV2 is slightly smaller than Ad2 . 
ORF3 has the potential to encode a 128 amino acid long polypeptide 
which shares 11.7% identity and 59% homology with the known Ad2 E4 
34kDa protein (Virtanen et al.,1984). The 96 amino acid long polypeptide 
encoded by ORF4 has 13.5% identity and 61 % homology to the E4 34kDa 
CA) 
CS) 
Ad2 MAAAVEALYVVLEREG- -- AI LPROEGF SGVYVF-FS PINFVI PP 
: I \,.: I : 1:: 11 I I : II I I: 
BAV2 M------ LF SFLLRAALPSAVLPKRAS-AGAAGYDLCASTYVEVP 
Ad2 M GA-VM.l SLRLRVCIPPGYFGRFLAL TDVNOPDV F TESY- ----
.. : 111 : 11 :: : 1: /I .. I 
BAV2 AGA RVL VPTGLK lSI PEGHYGPYV--- ---- RDVWACCYSGFNV 
Ad2 - -- IMT PDMTEELSVVLFNHGDOFFYGHAGMAVVRLMLI RVVFPV 
I I :: : I I : :: : I: I I: 
BAV2 GAGVI DCD YRGELFV LlFNHGNONYLI SPGO RV- -------- -- -
Ad2 VRO ASNV 
I: 
BA V2 --D A RYY 
BAV2 --- CY----OS TEKVFYSL --- -LSTFNEESSORW 1-- ------ -
111\1111 I I I . . 
Ad2 M I R CLRLK VEGALEO I FTMAGLN I RDL LRD I LI RWRDENYLGM VE 
BA V2 --- - - ---- ----YFVYVHOLOLO RARMGRRS VHEL -- -LL CG---
II :: : :111/ I : II: II: I 
Ad2 GAGMFI EEIHPEGFS LYVH-LDVRAVC LLEAI VOHLTNAII CSLAV 
BA V2 --EHLSRL EK V - LI DL YFEHGOFKHOK 
I: I : I: : ::::: II 
Ad2 EFDHATGGERVHLlDLHFEVLD-N LLE 
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Figure 31: Alignment of the amino acid sequence predicted from the BAV2 
ORF 1 and the known E4 14kDa (oRF I) protein of Ad2 (A), and ORF2 with the 
E4 13kDa (ORF3) protein of Ad2 (B). 
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protein of Ad12. ORFs 5 and 6 have the potential to encode for 31 and 57 
amino acid long polypeptides , respectively. The 31 amino acid long 
polypeptide has 24.8% identity and 70% homology to the E4 34kDa protein 
of Ad2, whereas the 57 amino acid long polypeptide encoded by ORF6 
shares 19.4% identity and 67% homology to the E4 34kDa protein of Ad2 
and 16.5% identity and 50% homology to the E4 34kDa protein of Ad12 . 
ORFs 3-6 encode polypeptides which all share homology to known E4 
34kDa protein . In addition to this, the nucleotide sequence of these four 
ORFs (1861-2818bp) share 54.9% identity with the nucleotide sequence of 
ORF6 (34kDa protein) of Ad2 (data not shown). The first ATG of ORF3 is 
found in a corresponding region (1861 bp) as the first ATG of ORF6 of Ad2. 
However, the ORF6 of Ad2 appears as one continuous ORF (Virtanen et 
al., 1 984) . In contrast, there are 4 non-continuous and partially 
overlapping ORFs present in this sequence which share homology to the E4 
34kDa protein of Ad2 (Figure 30). 
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CHAPTER 5: DISCUSSION 
The ultimate goal of our research group is to engineer a BAV2 gene 
transfer and expression vector analogous to the human Ad based vectors. · 
Although human Ads have proven to be very effective as gene transfer and 
expression vectors in cell culture and various animal models (Haj-Ahmad 
and Graham, 1986; Rosenfeld, 1991; Jaffe et al., 1992; Lemarchand et al., 
1993; Engelhardt et al., 1993; Rich et al., 1993; Li et al., 1993; Bout et al., 
1994; Brody et al., 1994), immunological memory poses a limitation on the 
use of these vectors in humans. A BAV2 based vector could overcome this 
limitation. 
The objectives of this study were to clone and reconstitute a BAV2 
E3 deletion mutant and to sequence the neighboring E4 region. The need 
for such work is, at least, fourfold. First, there are only two restriction 
enzyme maps (Belak et al., 1986 and Salmon et al., 1993) available for 
BAV2 for a limited number of enzymes. The sequence and restriction 
enzyme map for the E4 region would aid in designing strategies for 
molecular manipulation of the viral genome. Second, the availability of 
well characterized recombinant plasmids offer an inexpensive and 
inexhaustible source of DNA. Third, it is easier to carry out molecular 
manipulation, such as the deletion of the E3 region, on smaller plasmids 
rather than on an intact viral genome. Finally, a BAV2 E3 deletion mutant 
could be used as a recombinant vaccine analogous to the systems 
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established for human Ads (Johnson et al., 1988, Morin et al., 1987, Dewar 
et al., 1989, Schneider et al., 1989, Prevec et al., 1990, Collins et al., 
1990, and Hsu et al., 1991). A vaccine of this type could offer several 
advantages: it would be inexpensive, easy to administer and ought to 
provide long lasting immunity. 
The E3 region was deleted for three reasons: One, the E3 region is 
not required for the in vitro and in vivo growth of adenoviruses (Morin e t 
al., 1987; Ginsberg et al., 1989), however its gene products are 
responsible for counteracting host immunosurveillance. This has 
implications for the development of BAV2 as a viral vector. The maximum 
amount of DNA that can be packaged in the virions is approximately 105% 
of the wildtype genome (Ghosh-Choudhury et al., 1986). Recombinant Ads 
with genomes exceeding 105% undergo rapid rearrangement of the genome 
to lose the insert (Bett et al., 1993). To incorporate larger DNA segments, 
it is therefore necessary to delete appropriate areas of the genome. The 
2.3Kbp putative E3 region in BAV2 is larger than the E3 region in any other 
non-human Ad studied (Esford and Haj-Ahmad, 1994). Therefore, if this 
region is deleted in BAV2, the capacity of a DNA insert would increase to 
4.5Kbp. Secondly, the location and sequence of the E3 region of BAV2 was 
available (Esford and Haj-Ahmad, 1994), making the molecular 
manipulation of this area feasible. Finally, human Ads containing an E3 
deletion and a cloned foreign gene have been shown to raise neutralizing 
antibodies in a variety of animal species and protect them against 
subsequent challenge with the antigen (Johnson et al., 1988; Morin et al., 
1987; Dewar et al., 1989; Schneider et al., 1989; Prevec et al., 1 990; 
Collins et al., 1990; Hsu et al., 1991). An analogous system for BAV2 
could also be used as a recombinant vaccine. 
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During this study, the subcloning of pEA48 resulted in the 
construction of two recombinant plasmids with inserts spanning 65.2% to 
90.5% and 77.1 % to 90.5% of the the viral genome. The plasmid pPE1 has 
unique Pstl and Seal restriction enzyme sites which flank the E3 region, 
making the deletion of fhis region feasible. The precise deletion was 
confirmed by nucleotide sequencing of the multiple cloning site-BAV2 
junction. The determined nucleotide sequence of this junction shows that 
the deletion was precisely made between Pstl at 77.1 map units and Seal 
at 82.5 map units (removing a total of 1800bp), and didn't delete the E3 
promoter sequences or extend into the important sequences encoding 
structural proteins which exist on either side of the E3 region (Esford and 
Haj-Ahmad, 1994). Subsequent to this, five recombinant plasm ids of 
various sizes carrying a deletion in the E3 region were constructed 
spanning from 29.5 to 90.5 map units or 61 % of the entire genome. Of 
these 5 recombinant plasm ids, two have a reporter gene (tk) cloned into 
the unique Bam H I site at the MCS. The tk gene is used by cells in the 
salvage pathway of DNA synthesis and catalyses the formation of 
thymidine deo~yribose monophosphate (dTMP) from thymidine deoxyribose 
(TdR) (Cheng and Prusoff, 1974). The insertion of the tk gene served two 
purposes: One, the presence of tk sequences would enable the 
differentiation between a recombinant BAV2 vector and wtBAV2 using 
hybridization techniques with a tk labelled probe. Secondly, future 
experiments involving transient expression assays could be done to assess 
both tk expression and E3 promoter strength, both of which have been done 
before using human adenoviral systems (Haj-Ahmad and Graham, 1986; 
Nagpal and Ostrove, 1991). 
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During this investigation, the recombinant plasmid pdIE3-4tk1, 
spanning from 29.5 to 90.5 map units of the BAV2 viral genome with the 
tk gene cloned in the deleted E3 region was constructed. This plasmid was 
then used in the attempt to rescue a BAV2 E3 deletion mutant. First, 
MDBK cells were infected with wtBAV2, followed by transfection with 
banded pdIE3-4tk1, using the CaP04 precipitation method (Graham and van 
der Eb, 1973). Theoretically, a recombinant BAV2 vector would result 
from homologous recombination between the wtBA V2 genome and the 
recombinant plasmid. Hybridization results using Hirts extracted pooled 
viral DNA, digested with BamHI and BamHI+EcoRI and probed with 32p 
labelled tk173 show the expected 2Kbp band which co-migrated with the 
tk gene (See Figure 27). To further investigate this observation, 70 plaque 
purified virus were examined using restriction enzyme analysis and 
hybridization techniques. The BamHI digested DNA of 4 plaque-purified 
virus showed three bands when hybridized to 32p labelled tk173 and BAV2 
DNA. Of the two larger bands observed, one was approximately 20Kbp, of 
which an accurate size could not be determined and the other band 
observed was approximately 5.8Kbp. The size and position of these two 
larger bands correspond closely to the banding pattern of BamHI digested 
BAV2 DNA: 26Kbp and 5.8Kbp (Salmon et a/., 1993). Finally, the third band 
migrated slightly higher than the tk gene (2Kbp). There are two possible 
explanations for the tk fragment appearing larger than expected. One, is 
recombinantion events occurring in vivo and the second is gel shifting. 
Nonetheless, these hybridization results indicate the presence of tk 
sequences and a BAV2 E3 deletion mutant, however attempts to purify this 
mutant have been unsuccessful. 
Overall, 9 plasmids were constructed during this study. These 
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recombinant plasmids not only offer an inexhaustible and inexpensive 
source of DNA, they can be used as templates for future manipulation of 
the BAV2 genome and the construction of larger plasmids. The molecular 
manipulation of recombinant plasm ids IS much more practical than an 
intact viral genome. Two plasmids of particular interest are pd1E1-E and 
pd1E3-5 which span from 0 to 42.5 map units and 65.2 to 100 map units of 
the BAV2 genome, and contain a deletion within the E1 and E3 region, 
respectively. These two plasm ids could serve two purposes: one, they 
could be used individually in future experiments to co-infect a permissive 
cell line with BAV2 DNA to yield a recombinant BAV2 vector through 
homologous recombination, as described for human adenoviral systems 
(Graham and Prevec, 1991; 1992). However, the propagation of a BAV2 E1 
deletion mutant would require the establishment of a cell line which could 
constitutively express the E1 genes of BAV2 because the gene products of 
this region are required for viral growth. Secondly, pd1E3-5 and pd1E1-E 
could be used as templates for the construction of larger plasmids 
An essential step for deletion studies involving the BAV2 genome 
for the purpose of engineering a BAV2 viral vector is the sequencing and 
analysis of the early region genes. The E1 and E3 regions of BAV2 have 
been sequenced and analyzed (Esford and Haj-Ahmad, 1994; Salmon and 
Haj-Ahmad, 1994). However the E4 region of BAV2 has not been studied. 
The sequence and restriction enzyme map of this region would be a 
valuable tool for future studies involving BAV2 E4 deletions. Another 
reason for sequencing and analyzing the E4 region was to investigate the 
slow growth rate of BAV2 observed in MDBK cell line . Studies 
investigating the function of the E4 gene products of Ad2 and Ad5 show 
that mutants with a large deletion within the E4 region of their genome 
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display profound defects in the accumulation of late mRNAs both in the 
nucleus and the cytoplasm of infected cells, inefficient shutoff of host 
cell protein synthesis and reduced levels of viral DNA unless propagated in 
W162 cells which provide the missing functions of the E4 region in trans 
(Weinberg and Ketner, 1986; Sandler and Ketner, 1989). More specifically, 
the gene products encoded by ORF6 (34kDa) and ORF3 (13kDa) have 
redundant effects on viral infection. Both gene products augment viral 
DNA replication, viral late protein synthesis, the shutoff of host cell 
protein synthesis, and the production of infectious virus (Bridge and 
Ketner, 1989; Huang and Hearing, 1989). However, the product of ORF6 
(34kDa) is more efficient in the regulation of these processes than the 
product of ORF3 (13kDa). 
The nucleotide sequence of the extreme right end (90.5 to 100 map 
units) of the BAV2 genome containing the putative E4 region and the right 
ITR contains some conserved adenovirus landmarks such as the origin of 
replication (position 1-17) and the nuclear factor I binding site (position 
29-41). The right ITR sequence of BAV2 has 100% identity with the left 
ITR sequence (Salmon and Haj -Ahmad, 1994). Six ORFs encode 
polypeptides that have homology to the well characterized E4 proteins of 
human Ads .. 
In Ad2, E4 mRNAs are produced through a series of differential 
splicing of a primary transcript. It has been reported that the cap site for 
E4 mRNAs (5'-TTTTTA-3') is located between 324-329 bp (Virtanen et al., 
1984), whereas the poly(A) addition site follows the second A in the 
sequence 5'-CATAA-3' at position 3136 (Virtanen et al., 1984). The only 
potential cap site (TTTTA) in the putative E4 sequence of BAV2 is located 
at position 309 (30 bp upstream from the first ATG of ORF1). A possible 
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poly(A) site (ATAAAAA) is located at position 3104 (288 bp downstream 
from the stop codon for ORF6). 
ORF1 encodes a 114 amino acid long protein which has strong 
homology with the E4 t4kDa protein encoded by ORF1 of Ad2. The location 
and size of this ORF is remarkably similiar to the first ORF of the E4 
region of Ad2 (Virtanen et al., 1984) suggesting that this ORF is the first 
exon of the E4 transcription unit. The function of the 14kDa protein is not 
known. 
The 78 amino acid long protein encoded by ORF2 shares homology to 
the known Ad2 E4 13kDa protein of ORF3 (Virtanen et al., 1984) Although 
this ORF appears in a similar position, the protein encoded is slightly 
smaller than the 13kDa which may be accounted for by the fact that BAV2 
is slightly smaller than Ad2. Studies involving Ad2 and AdS mutants with 
deletions in both ORF3 and ORF6 (34kDa) were found to be severely 
defective for growth. However, mutants with a deletion only in ORF6 were 
partially defective for growth in HeLa cells suffering a 100 fold reduction 
in final virus yield when compared to wild-type virus. This suggested 
that the ORF3 gene product could compensate for the loss of the ORF6 gene 
product suffering only a moderately defective phenotype. 
ORFs 3-6 encode polypeptides which share homology to known E4 
34kDa protein. In addition to this, over half of the nucleotide sequence of 
these four ORFs is identitical to that of ORF6 (34kDa protein) of Ad2. The 
first ATG of ORF3 is found in a corresponding region (1861 bp) to the first 
ATG of ORF6 of Ad2. However, the ORF6 of Ad2 appears as one continuous 
ORF (Virtanen et al., 1984). In contrast, there are 4 non-continuous and 
partially overlapping ORFs present in this sequence which share homology 
to the E4 34kDa protein of Ad2. There are three possible explanations for 
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this observation. First, this may be simply due to error in the sequencing. 
However, repeated sequencing and analysis gave the same results. Second, 
it is reasonable to assume that the E4 34kOa protein in BAV2 is truncated. 
If a fully functional 34kOa protein is not being produced then other gene 
products of the E4 region could be functionally compensating for this loss, 
resulting in a moderately defective phenotype as observed in human Ad E4 
deletion mutants (Huang and Hearing, 1989). This could account for the 
slow growth rate observed for BAV2 in MOBK cells. However, further 
analysis involving the E4 gene products would be required in order to 
resolve this uncertainty. A third explanation cou ld be complex splicing, 
which appears unlikely because the ORFs are partially overlapping. Future 
studies designed to map the E4 mRNAs of BAV2 will need to be completed. 
These will include Northern blot analysis, cONA sequencing, and nuclease 
protection and primer extension assays. Other future experiments 
involving SOS-PAGE analysis or ELISA tests may be conducted to 
determine whether or not the 34kOa protein is present. 
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SUMMARY 
Based on the results obtained throughout this project the following 
conclusions can be made: 
(1) Several plasmids were constructed when subcloning the BAV2 
genome in pUC19: pSE1 and pPE1 
(2) A deletion of 1800 bp was made within the E3 region of BAV2 and a 
linker containing a multiple cloning site was subsequently inserted. 
(3) The BAV2 genome was reconstructed to contain from 29.5%-90.5% in 
pUC19 in a plasmid pdIE3-4. 
(4) The thymidine kinase gene along with its endogenous promoter was 
inserted in the E3 region in both orientations. 
(5) Southern Blotting and subsequent Hybridization with tk173 reveal 
that tk sequences are present within the viral DNA from purified 
plaque. This suggests the presence of a recombinant BAV2 vector 
carrying the tk gene in place of the E3 region. 
(6) The DNA sequence of the putative E4 region of BAV2 has been 
determined and the amino acid sequences of the 6 ORFs were 
compared to the amino acid sequences of proteins encoded by the E4 
region of Ad 2. 
-ORF1 was found to share 28.9% identity and 54.4% homology to the 
E4 14kDa protein of Ad2 
-ORF2 was found to share 11.3% identity and 40.2% homology to the 
13KDa protein encoded by the E4 region of Ad2 
-ORFs3-6 were found to share 11.7-24.8% identity and 59-70% 
similiarity to the 34KDa protein encoded by the E4 regions of Ad2 
and Ad12. 
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